| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 6.33e-09 | 7 | 252 | 5 | GO:0005234 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 4.19e-08 | 17 | 252 | 6 | GO:0004970 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 3.64e-07 | 6 | 252 | 4 | GO:0015277 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.23e-07 | 24 | 252 | 6 | GO:0099507 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 9.02e-07 | 27 | 252 | 6 | GO:0008066 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TSSK2 WNK1 PHKA1 CDKL5 PHKA2 CSNK1A1L CSNK1G1 SIK2 TSSK3 STK25 ADCK5 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 1.08e-06 | 446 | 252 | 20 | GO:0004674 |
| GeneOntologyMolecularFunction | neurexin family protein binding | 1.20e-06 | 16 | 252 | 5 | GO:0042043 | |
| GeneOntologyMolecularFunction | protein kinase activity | PDGFRA TSSK2 WNK1 PHKA1 CDKL5 PHKA2 CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 CAD ADCK5 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 2.44e-06 | 600 | 252 | 23 | GO:0004672 |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.69e-06 | 93 | 252 | 9 | GO:0097110 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | PDGFRA TSSK2 WNK1 PHKA1 CDKL5 PHKA2 FCSK CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 CAD ADCK5 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PANK4 PRKD1 MAP3K21 TSSK1B PLK4 | 3.87e-06 | 709 | 252 | 25 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 STK25 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 3.99e-06 | 363 | 252 | 17 | GO:0106310 |
| GeneOntologyMolecularFunction | oxidoreductase activity | CYP2A7 CYP2A13 AOC1 PIPOX ADH4 TXNRD1 LDHD ADHFE1 FASN MDH1B HSD17B3 PLOD1 D2HGDH DPYD PDPR HSDL2 AOC2 OGFOD2 CBR1 CRYZ SCCPDH FAR2 SDR42E2 PAH KDM2A HSD17B10 | 4.87e-06 | 766 | 252 | 26 | GO:0016491 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 7.37e-06 | 105 | 252 | 9 | GO:0015171 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | ADH4 LDHD ADHFE1 FASN MDH1B HSD17B3 D2HGDH CBR1 SDR42E2 HSD17B10 | 1.03e-05 | 138 | 252 | 10 | GO:0016614 |
| GeneOntologyMolecularFunction | kinase activity | PDGFRA TSSK2 WNK1 PHKA1 CDKL5 PHKA2 FCSK CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 CAD ADCK5 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PANK4 PRKD1 MAP3K21 TSSK1B PLK4 | 1.40e-05 | 764 | 252 | 25 | GO:0016301 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | LYPLA2 CDH23 ITGA7 ITGAM DSCAML1 SVEP1 FASN NRXN3 CDH20 NLGN4X NLGN2 NLGN4Y NLGN1 GRIN2B PPIA TENM4 CTTN TNR CDH6 CDH9 CDH11 | 2.59e-05 | 599 | 252 | 21 | GO:0050839 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.42e-05 | 127 | 252 | 9 | GO:0016616 | |
| GeneOntologyMolecularFunction | amino acid binding | 3.76e-05 | 73 | 252 | 7 | GO:0016597 | |
| GeneOntologyMolecularFunction | vitamin binding | 3.93e-05 | 161 | 252 | 10 | GO:0019842 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 5.32e-05 | 77 | 252 | 7 | GO:0005230 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN5A SLC17A7 SLC9A8 SLC17A4 GRIA2 SLC6A15 GRIK1 GRIK2 GRIK4 SLC6A7 | 6.54e-05 | 171 | 252 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 6.59e-05 | 18 | 252 | 4 | GO:0015280 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC17A7 ABCG2 GRIA1 GRIA2 SLC6A15 GRIK1 GRIK2 GRIK4 GRIN2B SLC2A1 SLC6A7 | 6.76e-05 | 207 | 252 | 11 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC17A7 ABCG2 GRIA1 GRIA2 SLC6A15 GRIK1 GRIK2 GRIK4 GRIN2B SLC2A1 SLC6A7 | 7.06e-05 | 208 | 252 | 11 | GO:0005342 |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 7.29e-05 | 56 | 252 | 6 | GO:0030170 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 8.06e-05 | 57 | 252 | 6 | GO:1904315 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 8.06e-05 | 57 | 252 | 6 | GO:0070279 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.06e-04 | 8 | 252 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.08e-04 | 60 | 252 | 6 | GO:0099529 | |
| GeneOntologyMolecularFunction | amide binding | ITGAM FZD6 FASN VDAC1 GRIA1 GRIA2 NLGN1 GRIN2B ECE1 PPIA PPIC PPIL1 HSD17B10 | 1.17e-04 | 299 | 252 | 13 | GO:0033218 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PDGFRA TSSK2 WNK1 PHKA1 CDKL5 PHKA2 FCSK CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 CAD ADCK5 PARP3 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PANK4 PRKD1 MAP3K21 TSSK1B PLK4 | 1.49e-04 | 938 | 252 | 26 | GO:0016772 |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 1.59e-04 | 2 | 252 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | histone H2BS36 kinase activity | 1.59e-04 | 2 | 252 | 2 | GO:0140823 | |
| GeneOntologyMolecularFunction | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity | 1.59e-04 | 2 | 252 | 2 | GO:0047322 | |
| GeneOntologyMolecularFunction | histone H2B kinase activity | 1.59e-04 | 2 | 252 | 2 | GO:0140998 | |
| GeneOntologyMolecularFunction | amino acid sensor activity | 1.59e-04 | 2 | 252 | 2 | GO:0140785 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.69e-04 | 65 | 252 | 6 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.69e-04 | 65 | 252 | 6 | GO:0022824 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.00e-04 | 43 | 252 | 5 | GO:0005231 | |
| GeneOntologyMolecularFunction | peptide binding | ITGAM FZD6 CSNK1A1L SEC61A1 PLOD1 DPP4 GRIA1 GRIA2 NUP214 NLGN1 GRIN2B SEC61A2 HSD17B10 | 2.15e-04 | 318 | 252 | 13 | GO:0042277 |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.13e-04 | 102 | 252 | 7 | GO:0001540 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC17A7 ABCG2 GRIA1 GRIA2 SLC6A15 GRIK1 GRIK2 GRIK4 GRIN2B SLC2A1 SLC6A7 SLC25A31 | 3.68e-04 | 293 | 252 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.70e-04 | 75 | 252 | 6 | GO:0098960 | |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 4.02e-04 | 12 | 252 | 3 | GO:0008239 | |
| GeneOntologyMolecularFunction | organic acid binding | HMGCS1 FCN1 UGT2B15 UGT2B17 PLOD1 CAD OGFOD2 GRIK1 GRIN2B PPIA THNSL2 | 4.03e-04 | 254 | 252 | 11 | GO:0043177 |
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 4.72e-04 | 3 | 252 | 2 | GO:0008389 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.93e-04 | 52 | 252 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNK9 SCN5A SLC17A7 SEC61A1 SLC9A8 SLC17A4 GRIA1 GRIA2 SLC6A15 GRIK1 GRIK2 KCNK12 GRIK4 GRIN2B SLC6A7 | 8.82e-04 | 465 | 252 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | phosphorylase kinase activity | 9.36e-04 | 4 | 252 | 2 | GO:0004689 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 9.36e-04 | 4 | 252 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | NADPH:quinone reductase activity | 9.36e-04 | 4 | 252 | 2 | GO:0003960 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 9.36e-04 | 4 | 252 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | FCN1 UGT2B15 UGT2B17 PLOD1 CAD OGFOD2 GRIK1 GRIN2B PPIA THNSL2 | 9.54e-04 | 239 | 252 | 10 | GO:0031406 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.30e-03 | 167 | 252 | 8 | GO:0015079 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 1.44e-03 | 39 | 252 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | C-palmitoyltransferase activity | 1.55e-03 | 5 | 252 | 2 | GO:0016454 | |
| GeneOntologyMolecularFunction | proline:sodium symporter activity | 1.55e-03 | 5 | 252 | 2 | GO:0005298 | |
| GeneOntologyMolecularFunction | serine C-palmitoyltransferase activity | 1.55e-03 | 5 | 252 | 2 | GO:0004758 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | KLHL2 AOC1 GALM PDGFRA HMGCS1 DSCAML1 RASIP1 SARS1 NLGN4X GLB1 ABCG2 KIT SPPL2C KYNU STK25 DPP4 DPYD NLGN4Y ECE1 TENM4 MAP3K21 | 1.62e-03 | 815 | 252 | 21 | GO:0042803 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.69e-03 | 100 | 252 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.90e-03 | 42 | 252 | 4 | GO:0015144 | |
| GeneOntologyMolecularFunction | FAD binding | 2.26e-03 | 44 | 252 | 4 | GO:0071949 | |
| GeneOntologyMolecularFunction | transition metal ion binding | CYP2A7 CYP2A13 AOC1 GALNT2 MYCBP2 PTER ADH4 TXNRD1 AHCY PLOD1 D2HGDH DPYD CAD AOC2 OGFOD2 DPP3 GRIN2B ZSWIM6 ECE1 TRIM16 CUTC LIG3 CRYZ IGHMBP2 PAH KDM2A SLFN11 | 2.30e-03 | 1189 | 252 | 27 | GO:0046914 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | KCNK9 SCN5A SLC17A7 SEC61A1 SLC9A8 SLC17A4 GRIA1 GRIA2 SLC6A15 GRIK1 GRIK2 KCNK12 GRIK4 GRIN2B SLC47A2 SLC6A7 SLC45A2 | 2.66e-03 | 627 | 252 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 2.89e-03 | 47 | 252 | 4 | GO:0016790 | |
| GeneOntologyMolecularFunction | cyclosporin A binding | 3.30e-03 | 24 | 252 | 3 | GO:0016018 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 3.62e-03 | 50 | 252 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 3.72e-03 | 25 | 252 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 3.72e-03 | 25 | 252 | 3 | GO:0055056 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 2.21e-08 | 16 | 251 | 6 | GO:0007158 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | CYP2A7 CYP2A13 MAT1A LYPLA2 PIPOX MCCC2 ADH4 TXNRD1 LDHD ADHFE1 FASN LIPG CSAD AHCY MDH1B SIK2 UGT2B15 UGT2B17 ACSBG2 KIT D2HGDH KYNU VDAC1 DPYD CAD ACOT1 CBR1 SLC2A1 PRKAA1 PRKAA2 PANK4 PAH SLC45A2 HSD17B10 THNSL2 | 4.32e-08 | 1035 | 251 | 35 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP2A7 CYP2A13 MAT1A LYPLA2 PIPOX MCCC2 ADH4 TXNRD1 LDHD ADHFE1 FASN LIPG CSAD AHCY MDH1B SIK2 UGT2B15 UGT2B17 ACSBG2 KIT D2HGDH KYNU VDAC1 DPYD CAD ACOT1 CBR1 SLC2A1 PRKAA1 PRKAA2 PANK4 PAH SLC45A2 HSD17B10 THNSL2 | 7.40e-08 | 1058 | 251 | 35 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP2A7 CYP2A13 MAT1A LYPLA2 PIPOX MCCC2 ADH4 TXNRD1 LDHD ADHFE1 FASN LIPG CSAD AHCY MDH1B SIK2 UGT2B15 UGT2B17 ACSBG2 KIT D2HGDH KYNU VDAC1 DPYD CAD ACOT1 CBR1 SLC2A1 PRKAA1 PRKAA2 PANK4 PAH SLC45A2 HSD17B10 THNSL2 | 8.48e-08 | 1064 | 251 | 35 | GO:0006082 |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 1.12e-07 | 11 | 251 | 5 | GO:0097104 | |
| GeneOntologyBiologicalProcess | L-amino acid catabolic process | 5.54e-07 | 80 | 251 | 9 | GO:0170035 | |
| GeneOntologyBiologicalProcess | alpha-amino acid catabolic process | 5.70e-07 | 104 | 251 | 10 | GO:1901606 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | SLC17A7 SYT1 NLGN2 GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B TNR | 6.59e-07 | 132 | 251 | 11 | GO:0035249 |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 7.31e-07 | 27 | 251 | 6 | GO:0035235 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | GALC CEL MAT1A LYPLA2 PIPOX MCCC2 WNK1 ADH4 TXNRD1 PHKA1 RASIP1 LDHD ADHFE1 GLB1 LIPG CSAD AHCY UGT2B15 UGT2B17 ACSBG2 HERC1 KYNU VDAC1 SPTLC2 AMBRA1 ACOT1 ECE1 CRYZ PRKAA1 PRKAA2 PAH GPR137B PRKD1 HSD17B10 THNSL2 CTTN | 1.41e-06 | 1253 | 251 | 36 | GO:0044248 |
| GeneOntologyBiologicalProcess | amino acid catabolic process | 1.70e-06 | 117 | 251 | 10 | GO:0009063 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | NLGN4X SLC17A7 NLGN2 GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B CNTNAP2 GRIP2 | 2.21e-06 | 180 | 251 | 12 | GO:0060078 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 3.48e-06 | 53 | 251 | 7 | GO:0016339 | |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 MYCBP2 PCDHB5 CSMD2 ITGAM MAGI2 CDKL5 NRXN3 NLGN4X GPC4 NLGN2 NLGN4Y GRIA1 NLGN1 GRIN2B OPA1 TENM4 CNTNAP2 CHRD GRIP2 CTTN TNR CDH6 CDH9 | 3.69e-06 | 685 | 251 | 24 | GO:0050808 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 4.25e-06 | 10 | 251 | 4 | GO:0097105 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHB5 CDH23 ITGAM WNK1 DSCAML1 MAGI2 FAT1 CDH20 GPC4 DSC1 NLGN1 TENM4 CDH6 CDH9 CDH11 | 7.39e-06 | 313 | 251 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PDGFRA PCDHB5 CDH23 ITGA7 ITGAM WNK1 DSCAML1 SVEP1 MAGI2 FAT1 NRXN3 CDH20 NLGN4X GPC4 PKHD1 NLGN2 CHST2 KIT DPP4 DSC1 NLGN4Y AMBRA1 NLGN1 PPIA OPA1 TENM4 HAS2 TNR CDH6 CDH9 CDH11 | 7.90e-06 | 1077 | 251 | 31 | GO:0098609 |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 8.30e-06 | 40 | 251 | 6 | GO:1990806 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 MYCBP2 PCDHB5 CSMD2 ITGAM SVEP1 MAGI2 RHPN1 CDKL5 NRXN3 CDH20 NLGN4X GPC4 PKHD1 NLGN2 NLGN4Y GRIA1 NLGN1 GRIN2B OPA1 TENM4 CNTNAP2 CHRD GRIP2 CTTN TNR CDH6 CDH9 CDH11 | 8.41e-06 | 974 | 251 | 29 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 MYCBP2 LYPLA2 CDH23 PDZD7 ITGA7 DSCAML1 RHPN1 CDKL5 FAT1 NRXN3 CSNK1A1L CDH20 PTPRQ PKHD1 SYT1 FGD5 KIT NOVA2 STK25 NLGN1 ZSWIM6 ECE1 THOC2 OPA1 FRY CNTNAP2 CTTN TNR CDH6 CDH9 CDH11 TOP2B | 9.14e-06 | 1194 | 251 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 9.70e-06 | 142 | 251 | 10 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 9.70e-06 | 142 | 251 | 10 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 9.70e-06 | 142 | 251 | 10 | GO:0034032 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | MAT1A PIPOX MCCC2 TXNRD1 ADHFE1 CSAD AHCY KYNU CAD PAH SLC45A2 THNSL2 | 9.79e-06 | 208 | 251 | 12 | GO:0170033 |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.11e-05 | 42 | 251 | 6 | GO:0099560 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | MAT1A PIPOX MCCC2 TXNRD1 ADHFE1 CSAD AHCY KYNU CAD PAH SLC45A2 HSD17B10 THNSL2 | 1.33e-05 | 251 | 251 | 13 | GO:1901605 |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.39e-05 | 65 | 251 | 7 | GO:0098815 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.40e-05 | 13 | 251 | 4 | GO:0097090 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | MAT1A PIPOX MCCC2 TXNRD1 ADHFE1 SARS1 CSAD AHCY KYNU DPYD CAD PAH SLC45A2 HSD17B10 THNSL2 | 1.49e-05 | 332 | 251 | 15 | GO:0006520 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.66e-05 | 92 | 251 | 8 | GO:0051966 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 1.66e-05 | 27 | 251 | 5 | GO:0060080 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 3.11e-05 | 130 | 251 | 9 | GO:0060079 | |
| GeneOntologyBiologicalProcess | postsynapse organization | TANC2 CSMD2 MAGI2 CDKL5 NRXN3 NLGN4X NLGN2 NLGN4Y NLGN1 GRIN2B OPA1 CNTNAP2 GRIP2 CTTN | 3.20e-05 | 313 | 251 | 14 | GO:0099173 |
| GeneOntologyBiologicalProcess | proteinogenic amino acid catabolic process | 3.57e-05 | 75 | 251 | 7 | GO:0170040 | |
| GeneOntologyBiologicalProcess | acyl-CoA metabolic process | 5.67e-05 | 109 | 251 | 8 | GO:0006637 | |
| GeneOntologyBiologicalProcess | thioester metabolic process | 5.67e-05 | 109 | 251 | 8 | GO:0035383 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | NLGN4X NLGN2 GRIK1 GRIK2 NLGN1 GRIN2B TENM4 CNTNAP2 GRIP2 TNR | 5.88e-05 | 175 | 251 | 10 | GO:0031644 |
| GeneOntologyBiologicalProcess | amide metabolic process | SPTLC3 GALC CEL PIPOX HMGCS1 FASN ACSBG2 KYNU VDAC1 DPP4 SPTLC2 ACOT1 ECE1 FAR2 CSNK1E PRKAA1 PANK4 ECE2 | 5.88e-05 | 511 | 251 | 18 | GO:0043603 |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 5.97e-05 | 56 | 251 | 6 | GO:0001941 | |
| GeneOntologyBiologicalProcess | negative regulation of tubulin deacetylation | 6.01e-05 | 7 | 251 | 3 | GO:1904428 | |
| GeneOntologyBiologicalProcess | learning | B4GALT2 NRXN3 NLGN4X KIT VDAC1 NLGN4Y GRIN2B CNTNAP2 CHRD TNR NDRG4 | 6.08e-05 | 212 | 251 | 11 | GO:0007612 |
| GeneOntologyBiologicalProcess | small molecule catabolic process | GALM MAT1A PIPOX MCCC2 ADH4 LDHD ADHFE1 GLB1 CSAD AHCY ACSBG2 KYNU DPYD PAH HSD17B10 THNSL2 | 6.30e-05 | 421 | 251 | 16 | GO:0044282 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 8.03e-05 | 59 | 251 | 6 | GO:0007215 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 8.12e-05 | 147 | 251 | 9 | GO:0099565 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 9.27e-05 | 38 | 251 | 5 | GO:1902473 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | B4GALT2 GALC GALNT2 SLC35C1 PIPOX HMGCS1 MCCC2 FCSK LDHD FASN GLB1 AHCY SIK2 ACSBG2 ABCG2 CHST2 KIT PLOD1 KYNU VDAC1 DPYD CAD ACOT1 OPA1 STT3B SCCPDH FAR2 PRKAA1 PRKAA2 PANK4 HAS2 | 9.29e-05 | 1226 | 251 | 31 | GO:1901135 |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 9.35e-05 | 185 | 251 | 10 | GO:0170039 | |
| GeneOntologyBiologicalProcess | brainstem development | 9.53e-05 | 8 | 251 | 3 | GO:0003360 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 9.53e-05 | 8 | 251 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | acetyl-CoA metabolic process | 1.05e-04 | 39 | 251 | 5 | GO:0006084 | |
| GeneOntologyBiologicalProcess | synapse assembly | MYCBP2 PCDHB5 CSMD2 MAGI2 NRXN3 NLGN4X GPC4 NLGN2 NLGN4Y GRIA1 NLGN1 CNTNAP2 CDH9 | 1.10e-04 | 308 | 251 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | PDGFRA TSSK2 CDKL5 SIK2 KIT STK25 CAD MKNK1 PIM3 PRKD1 MAP3K21 | 1.16e-04 | 228 | 251 | 11 | GO:0046777 |
| GeneOntologyBiologicalProcess | organic acid catabolic process | MAT1A PIPOX MCCC2 LDHD ADHFE1 CSAD AHCY ACSBG2 KYNU PAH HSD17B10 THNSL2 | 1.34e-04 | 272 | 251 | 12 | GO:0016054 |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | MAT1A PIPOX MCCC2 LDHD ADHFE1 CSAD AHCY ACSBG2 KYNU PAH HSD17B10 THNSL2 | 1.34e-04 | 272 | 251 | 12 | GO:0046395 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 1.41e-04 | 93 | 251 | 7 | GO:0099068 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | PIPOX HMGCS1 MCCC2 TXNRD1 LDHD FASN AHCY MDH1B SIK2 ACSBG2 ABCG2 KYNU VDAC1 DPYD ACOT1 OPA1 FAR2 PRKAA1 PRKAA2 PANK4 | 1.52e-04 | 652 | 251 | 20 | GO:0072521 |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | MAT1A MAT2A PIPOX HMGCS1 FASN GLB1 CSAD AHCY ACSBG2 CHST2 KYNU VDAC1 ACOT1 FAR2 | 1.64e-04 | 365 | 251 | 14 | GO:0006790 |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 1.73e-04 | 96 | 251 | 7 | GO:0048488 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.88e-04 | 24 | 251 | 4 | GO:0071625 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | WNK1 CDKL5 NRXN3 NLGN4X SYT1 NLGN2 KIT NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B CNTNAP2 CHRD GRIP2 TNR CDH11 | 1.90e-04 | 663 | 251 | 20 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | WNK1 CDKL5 NRXN3 NLGN4X SYT1 NLGN2 KIT NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B CNTNAP2 CHRD GRIP2 TNR CDH11 | 1.94e-04 | 664 | 251 | 20 | GO:0099177 |
| GeneOntologyBiologicalProcess | learning or memory | B4GALT2 NRXN3 NLGN4X SLC17A7 KIT VDAC1 NLGN4Y GRIA1 GRIN2B CNTNAP2 CHRD TNR NDRG4 VPS13B | 2.06e-04 | 373 | 251 | 14 | GO:0007611 |
| GeneOntologyBiologicalProcess | neuron development | TANC2 MYCBP2 LYPLA2 CDH23 PDZD7 WNK1 CSMD3 DSCAML1 MAGI2 CDKL5 NRXN3 PTPRQ SYT1 NLGN2 HERC1 NOVA2 STK25 KLHL1 NLGN1 ZSWIM6 ECE1 THOC2 OPA1 FRY TENM4 CNTNAP2 PRKD1 GRIP2 CTTN TNR NDRG4 CDH11 VPS13B TOP2B | 2.10e-04 | 1463 | 251 | 34 | GO:0048666 |
| GeneOntologyBiologicalProcess | response to nutrient levels | AOC1 MAT2A CSNK1A1L LIPG AGL AHCY SIK2 KYNU DPYD CAD AMBRA1 SAR1A SLC2A1 SAR1B PRKAA1 PRKAA2 CNTNAP2 PRKD1 | 2.11e-04 | 566 | 251 | 18 | GO:0031667 |
| GeneOntologyBiologicalProcess | cell junction assembly | MYCBP2 PCDHB5 CSMD2 MAGI2 RHPN1 NRXN3 CDH20 NLGN4X GPC4 NLGN2 NLGN4Y GRIA1 NLGN1 CNTNAP2 CTTN CDH6 CDH9 CDH11 | 2.25e-04 | 569 | 251 | 18 | GO:0034329 |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 2.34e-04 | 46 | 251 | 5 | GO:1904861 | |
| GeneOntologyBiologicalProcess | behavior | B4GALT2 CDH23 NRXN3 NLGN4X AHCY SLC17A7 NLGN2 KIT VDAC1 DPP4 KLHL1 NLGN4Y GRIA1 GRIK1 GRIK2 NLGN1 GRIN2B CSNK1E PRKAA1 CNTNAP2 CHRD TNR NDRG4 VPS13B | 2.41e-04 | 891 | 251 | 24 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of TORC1 signaling | 2.51e-04 | 102 | 251 | 7 | GO:1903432 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 2.51e-04 | 102 | 251 | 7 | GO:0140238 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP2A7 CYP2A13 LYPLA2 ADH4 LDHD FASN LIPG SIK2 UGT2B15 UGT2B17 ACSBG2 KIT KYNU VDAC1 ACOT1 CBR1 PRKAA1 PRKAA2 PANK4 HSD17B10 THNSL2 | 2.54e-04 | 731 | 251 | 21 | GO:0032787 |
| GeneOntologyBiologicalProcess | social behavior | 2.84e-04 | 74 | 251 | 6 | GO:0035176 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | PIPOX HMGCS1 MCCC2 TXNRD1 FCSK LDHD FASN MDH1B SIK2 ACSBG2 KYNU VDAC1 DPYD CAD ACOT1 OPA1 FAR2 PRKAA1 PRKAA2 PANK4 | 2.85e-04 | 684 | 251 | 20 | GO:0009117 |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | PIPOX HMGCS1 MCCC2 LDHD FASN SIK2 ACSBG2 KYNU VDAC1 DPYD CAD ACOT1 OPA1 FAR2 PRKAA1 PRKAA2 PANK4 | 3.05e-04 | 533 | 251 | 17 | GO:0009259 |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 3.16e-04 | 176 | 251 | 9 | GO:0006665 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | PIPOX HMGCS1 MCCC2 TXNRD1 FCSK LDHD FASN MDH1B SIK2 ACSBG2 KYNU VDAC1 DPYD CAD ACOT1 OPA1 FAR2 PRKAA1 PRKAA2 PANK4 | 3.24e-04 | 691 | 251 | 20 | GO:0006753 |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 3.28e-04 | 76 | 251 | 6 | GO:0051703 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 3.39e-04 | 141 | 251 | 8 | GO:0006805 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | PIPOX HMGCS1 MCCC2 LDHD FASN SIK2 ACSBG2 KYNU VDAC1 DPYD CAD ACOT1 OPA1 FAR2 PRKAA1 PRKAA2 PANK4 | 3.54e-04 | 540 | 251 | 17 | GO:0019693 |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 3.61e-04 | 12 | 251 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | TORC1 signaling | 3.77e-04 | 109 | 251 | 7 | GO:0038202 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | AOC1 MAT2A CSNK1A1L SIK2 AMBRA1 SAR1A SLC2A1 SAR1B PRKAA1 PRKAA2 PRKD1 | 3.86e-04 | 262 | 251 | 11 | GO:0031669 |
| GeneOntologyBiologicalProcess | TOR signaling | MAT2A CSNK1A1L PKHD1 SAR1A SAR1B PRKAA1 PRKAA2 CNTNAP2 GPR137B | 3.88e-04 | 181 | 251 | 9 | GO:0031929 |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | CYP2A7 CYP2A13 UGT2B15 UGT2B17 CAD AOC2 CBR1 CRYZ PRKAA1 PRKAA2 | 4.09e-04 | 222 | 251 | 10 | GO:0071466 |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 4.21e-04 | 111 | 251 | 7 | GO:0036465 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 4.39e-04 | 3 | 251 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | neuromuscular process | MYCBP2 CDH23 PTPRQ NLGN2 HERC1 GRIN2B IGHMBP2 CNTNAP2 PRKD1 TNR | 4.54e-04 | 225 | 251 | 10 | GO:0050905 |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 4.57e-04 | 53 | 251 | 5 | GO:0044273 | |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 MYCBP2 LYPLA2 CDH23 PDZD7 CSMD3 DSCAML1 MAGI2 CDKL5 NRXN3 SYT1 NLGN2 HERC1 NOVA2 STK25 KLHL1 NLGN1 ZSWIM6 ECE1 THOC2 OPA1 FRY CNTNAP2 PRKD1 CTTN TNR NDRG4 CDH11 VPS13B TOP2B | 4.72e-04 | 1285 | 251 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | PIPOX HMGCS1 MCCC2 TXNRD1 FCSK LDHD FASN AHCY MDH1B SIK2 ACSBG2 KYNU VDAC1 DPYD CAD ACOT1 OPA1 FAR2 PRKAA1 PRKAA2 PANK4 | 4.80e-04 | 767 | 251 | 21 | GO:0055086 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.92e-04 | 187 | 251 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | rhythmic process | PDGFRA MYCBP2 MAT2A AHCY DPYD NLGN1 GRIN2B CSNK1E PRKAA1 PRKAA2 CNTNAP2 KDM2A HAS2 | 4.97e-04 | 360 | 251 | 13 | GO:0048511 |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 5.20e-04 | 31 | 251 | 4 | GO:0051291 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 5.21e-04 | 229 | 251 | 10 | GO:0006643 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 5.22e-04 | 115 | 251 | 7 | GO:0035418 | |
| GeneOntologyBiologicalProcess | receptor clustering | 5.28e-04 | 83 | 251 | 6 | GO:0043113 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 5.89e-04 | 32 | 251 | 4 | GO:0099505 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 5.96e-04 | 233 | 251 | 10 | GO:0050806 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system process | 6.41e-04 | 57 | 251 | 5 | GO:0031646 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 6.64e-04 | 156 | 251 | 8 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 6.64e-04 | 156 | 251 | 8 | GO:0010927 | |
| GeneOntologyCellularComponent | excitatory synapse | NLGN4X SLC17A7 SYT1 NLGN2 NLGN4Y GRIA1 GRIA2 NLGN1 GRIN2B CNTNAP2 | 6.84e-07 | 107 | 252 | 10 | GO:0060076 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 CSMD2 MAGI2 CDKL5 NLGN4X SYT1 NLGN2 VDAC1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B CNTNAP2 GRIP2 TNR CDH9 | 6.05e-06 | 523 | 252 | 20 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | CSMD2 NLGN4X NLGN2 VDAC1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B | 6.30e-06 | 201 | 252 | 12 | GO:0099634 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 CSMD2 MAGI2 CDKL5 NRXN3 NLGN4X GPC4 SYT1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B GPC6 SLC6A7 TENM4 CNTNAP2 GRIP2 CTTN TNR CDH6 CDH9 CDH11 | 6.84e-06 | 817 | 252 | 26 | GO:0098978 |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 6.86e-06 | 4 | 252 | 3 | GO:0098983 | |
| GeneOntologyCellularComponent | presynaptic membrane | NRXN3 GPC4 SYT1 NLGN2 VDAC1 GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 GRIN2B SLC6A7 CNTNAP2 CDH9 | 7.38e-06 | 277 | 252 | 14 | GO:0042734 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.59e-05 | 45 | 252 | 6 | GO:0008328 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | CSMD2 NLGN4X VDAC1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 GRIN2B | 2.15e-05 | 157 | 252 | 10 | GO:0098839 |
| GeneOntologyCellularComponent | synaptic membrane | CSMD2 MAGI2 NRXN3 NLGN4X GPC4 SYT1 NLGN2 VDAC1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B SLC6A7 CNTNAP2 GRIP2 CDH9 | 2.90e-05 | 583 | 252 | 20 | GO:0097060 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.95e-05 | 50 | 252 | 6 | GO:0098878 | |
| GeneOntologyCellularComponent | axon | TANC2 PDGFRA MYCBP2 DSCAML1 KLHL20 CDKL5 AP3S1 SCN5A SLC17A7 SYT1 NLGN2 CAD GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 GRIN2B OPA1 CSNK1E IGHMBP2 PRKAA1 PRKAA2 CNTNAP2 CTTN CDH9 | 3.05e-05 | 891 | 252 | 26 | GO:0030424 |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 3.37e-05 | 6 | 252 | 3 | GO:0032983 | |
| GeneOntologyCellularComponent | catenin complex | 3.78e-05 | 32 | 252 | 5 | GO:0016342 | |
| GeneOntologyCellularComponent | stereocilium tip | 1.27e-04 | 22 | 252 | 4 | GO:0032426 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CSMD2 MAGI2 NLGN4X NLGN2 VDAC1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B GRIP2 CDH9 | 1.28e-04 | 405 | 252 | 15 | GO:0045211 |
| GeneOntologyCellularComponent | anchoring junction | IL16 AOC1 PCDHB5 AQP7P3 ITGA7 MAGI2 RASIP1 FAT1 CDH20 SCN5A KIT FLII DPP4 FLNC KIF23 DSC1 AMBRA1 GRIA1 PPIA SLC2A1 CNTNAP2 PRKD1 CTTN CDH6 CDH9 CDH11 | 1.36e-04 | 976 | 252 | 26 | GO:0070161 |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 1.56e-04 | 67 | 252 | 6 | GO:0098686 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.81e-04 | 24 | 252 | 4 | GO:0098985 | |
| GeneOntologyCellularComponent | stereocilium | 1.84e-04 | 69 | 252 | 6 | GO:0032420 | |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 CSMD2 MAGI2 CDKL5 NLGN4X VDAC1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B CNTNAP2 GRIP2 | 2.37e-04 | 477 | 252 | 16 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 3.03e-04 | 49 | 252 | 5 | GO:0099092 | |
| GeneOntologyCellularComponent | cell-cell junction | AOC1 PCDHB5 AQP7P3 MAGI2 RASIP1 FAT1 CDH20 SCN5A KIT DPP4 DSC1 GRIA1 SLC2A1 CNTNAP2 PRKD1 CDH6 CDH9 CDH11 | 3.17e-04 | 591 | 252 | 18 | GO:0005911 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.60e-04 | 78 | 252 | 6 | GO:0048787 | |
| GeneOntologyCellularComponent | stereocilium bundle | 3.85e-04 | 79 | 252 | 6 | GO:0032421 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.86e-04 | 29 | 252 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MORN4 CDH23 PDZD7 AQP7P3 PTPRQ ABCG2 FLII SLC17A4 ZSWIM6 PKHD1L1 | 3.94e-04 | 223 | 252 | 10 | GO:0098862 |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 CSMD2 MAGI2 CDKL5 NLGN4X VDAC1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B GRIP2 | 4.05e-04 | 451 | 252 | 15 | GO:0014069 |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 CSMD2 MAGI2 CDKL5 NLGN4X NLGN2 VDAC1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B GRIP2 | 4.26e-04 | 503 | 252 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 4.31e-04 | 3 | 252 | 2 | GO:0048269 | |
| GeneOntologyCellularComponent | symmetric synapse | 4.53e-04 | 13 | 252 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | inhibitory synapse | 5.02e-04 | 31 | 252 | 4 | GO:0060077 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 5.66e-04 | 56 | 252 | 5 | GO:0099091 | |
| GeneOntologyCellularComponent | dendrite | TANC2 KLHL20 MAGI2 CDKL5 NLGN4X NLGN2 KLHL1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B OPA1 PRKAA1 PRKAA2 CNTNAP2 GRIP2 CTTN CDH9 | 7.47e-04 | 858 | 252 | 22 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 KLHL20 MAGI2 CDKL5 NLGN4X NLGN2 KLHL1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B OPA1 PRKAA1 PRKAA2 CNTNAP2 GRIP2 CTTN CDH9 | 7.70e-04 | 860 | 252 | 22 | GO:0097447 |
| GeneOntologyCellularComponent | perisynaptic space | 8.55e-04 | 4 | 252 | 2 | GO:0099544 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | B4GALT2 RABEPK GALNT2 LYPLA2 KLHL20 RASIP1 AP3S1 CHST2 SLC9A8 SAR1A SAR1B PRKD1 VPS13B ECE2 | 1.03e-03 | 443 | 252 | 14 | GO:0098791 |
| GeneOntologyCellularComponent | terminal bouton | 1.08e-03 | 96 | 252 | 6 | GO:0043195 | |
| GeneOntologyCellularComponent | presynapse | KCNK9 AP3S1 NRXN3 NLGN4X GPC4 SLC17A7 SYT1 NLGN2 VDAC1 CAD NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B SLC2A1 SLC6A7 CNTNAP2 CDH9 | 1.13e-03 | 886 | 252 | 22 | GO:0098793 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.39e-03 | 137 | 252 | 7 | GO:0019897 | |
| GeneOntologyCellularComponent | phosphorylase kinase complex | 1.41e-03 | 5 | 252 | 2 | GO:0005964 | |
| GeneOntologyCellularComponent | Sec61 translocon complex | 1.41e-03 | 5 | 252 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.64e-03 | 141 | 252 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | transport vesicle | RABEPK SYTL2 KCNK9 AP3S1 TMEM184A SLC17A7 SYT1 VDAC1 GRIA1 GRIA2 GRIN2B SAR1A SLC6A7 SAR1B ECE2 | 1.67e-03 | 519 | 252 | 15 | GO:0030133 |
| GeneOntologyCellularComponent | glycinergic synapse | 1.70e-03 | 20 | 252 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | dendritic shaft | 2.00e-03 | 74 | 252 | 5 | GO:0043198 | |
| GeneOntologyCellularComponent | cell surface | PDGFRA ITGA7 ITGAM DSCAML1 FZD6 NLGN4X FCN1 LIPG SCN5A GPC4 PKHD1 NLGN2 ABCG2 KIT DPP4 NLGN4Y GRIA1 GRIA2 NLGN1 GRIN2B ECE1 GPC6 CNTNAP2 CHRD TNR | 2.06e-03 | 1111 | 252 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | actin-based cell projection | MORN4 PDGFRA CDH23 PDZD7 FAT1 PTPRQ NLGN1 ZSWIM6 CBR1 PKHD1L1 | 2.10e-03 | 278 | 252 | 10 | GO:0098858 |
| GeneOntologyCellularComponent | translocon complex | 2.10e-03 | 6 | 252 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | Z disc | 2.41e-03 | 151 | 252 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 2.92e-03 | 7 | 252 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | transport vesicle membrane | TMEM184A SLC17A7 SYT1 GRIA1 GRIA2 GRIN2B SAR1A SLC6A7 SAR1B ECE2 | 3.06e-03 | 293 | 252 | 10 | GO:0030658 |
| GeneOntologyCellularComponent | pore complex | 3.67e-03 | 26 | 252 | 3 | GO:0046930 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 3.82e-03 | 164 | 252 | 7 | GO:0098982 | |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 KLHL20 TXNRD1 MAGI2 CDKL5 NLGN4X NLGN2 CAD KLHL1 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B OPA1 CSNK1E IGHMBP2 PRKAA1 PRKAA2 CNTNAP2 GRIP2 CTTN CDH9 | 3.82e-03 | 1228 | 252 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | serine palmitoyltransferase complex | 3.86e-03 | 8 | 252 | 2 | GO:0017059 | |
| GeneOntologyCellularComponent | I band | 4.08e-03 | 166 | 252 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | membrane protein complex | ENTR1 CDH23 ITGA7 ITGAM LIME1 AP3S1 CDH20 SCN5A SLC17A7 C8A SEC61A1 VDAC1 SEL1L GRIA1 GRIA2 GRIK1 GRIK2 KCNK12 GRIK4 GRIN2B SAR1A STT3B SEC61A2 SAR1B CNTNAP2 CTTN CDH6 CDH9 CDH11 SLC25A31 | 4.31e-03 | 1498 | 252 | 30 | GO:0098796 |
| GeneOntologyCellularComponent | secretory vesicle | AOC1 CEL SYTL2 TSSK2 ITGAM KCNK9 GLB1 TMEM184A FCN1 AGL SLC17A7 SYT1 KIT VDAC1 SLC9A8 DSC1 GRIA1 GRIA2 GRIN2B ECE1 PPIA SLC6A7 SCCPDH PRCP TSSK1B VPS13B | 4.62e-03 | 1246 | 252 | 26 | GO:0099503 |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle membrane | 4.93e-03 | 9 | 252 | 2 | GO:0060203 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle | 4.93e-03 | 9 | 252 | 2 | GO:0060199 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum membrane | 5.02e-03 | 29 | 252 | 3 | GO:0030867 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 5.59e-03 | 59 | 252 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | perineuronal net | 6.11e-03 | 10 | 252 | 2 | GO:0072534 | |
| Domain | - | LYPLA2 TMCO4 FASN NLGN4X LIPG NLGN2 DPP4 NLGN4Y ACOT1 NLGN1 TEX30 PRCP NDRG4 | 7.55e-09 | 119 | 251 | 13 | 3.40.50.1820 |
| Domain | AB_hydrolase | LYPLA2 TMCO4 FASN NLGN4X LIPG NLGN2 DPP4 NLGN4Y ACOT1 NLGN1 TEX30 PRCP NDRG4 | 7.55e-09 | 119 | 251 | 13 | IPR029058 |
| Domain | Lig_chan-Glu_bd | 9.00e-08 | 18 | 251 | 6 | PF10613 | |
| Domain | Glu/Gly-bd | 9.00e-08 | 18 | 251 | 6 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 9.00e-08 | 18 | 251 | 6 | SM00918 | |
| Domain | Iontro_rcpt | 9.00e-08 | 18 | 251 | 6 | IPR001320 | |
| Domain | Iono_rcpt_met | 9.00e-08 | 18 | 251 | 6 | IPR001508 | |
| Domain | Lig_chan | 9.00e-08 | 18 | 251 | 6 | PF00060 | |
| Domain | PBPe | 9.00e-08 | 18 | 251 | 6 | SM00079 | |
| Domain | Nlgn | 1.58e-07 | 5 | 251 | 4 | IPR000460 | |
| Domain | Gal_Oxidase_b-propeller | 2.87e-07 | 34 | 251 | 7 | IPR015916 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 3.48e-07 | 69 | 251 | 9 | IPR020636 | |
| Domain | Carboxylesterase_B_CS | 4.96e-07 | 13 | 251 | 5 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 7.64e-07 | 14 | 251 | 5 | PS00941 | |
| Domain | COesterase | 7.64e-07 | 14 | 251 | 5 | PF00135 | |
| Domain | CarbesteraseB | 7.64e-07 | 14 | 251 | 5 | IPR002018 | |
| Domain | BACK | 1.33e-06 | 60 | 251 | 8 | SM00875 | |
| Domain | BACK | 1.52e-06 | 61 | 251 | 8 | IPR011705 | |
| Domain | BACK | 1.52e-06 | 61 | 251 | 8 | PF07707 | |
| Domain | NAD(P)-bd_dom | ADH4 FASN AHCY MDH1B HSD17B3 HSDL2 CBR1 CRYZ SCCPDH FAR2 SDR42E2 HSD17B10 | 4.01e-06 | 173 | 251 | 12 | IPR016040 |
| Domain | Protein_kinase_ATP_BS | PDGFRA TSSK2 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 4.02e-06 | 379 | 251 | 18 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | PDGFRA TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 ADCK5 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 4.28e-06 | 459 | 251 | 20 | PS00107 |
| Domain | Kelch_1 | 4.38e-06 | 70 | 251 | 8 | PF01344 | |
| Domain | Kelch_1 | 4.38e-06 | 70 | 251 | 8 | IPR006652 | |
| Domain | S_TKc | PDGFRA TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 STK25 MKNK1 PIM3 PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 7.79e-06 | 359 | 251 | 17 | SM00220 |
| Domain | PROTEIN_KINASE_ST | TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 STK25 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 8.68e-06 | 362 | 251 | 17 | PS00108 |
| Domain | ANF_lig-bd_rcpt | 9.10e-06 | 37 | 251 | 6 | IPR001828 | |
| Domain | ANF_receptor | 9.10e-06 | 37 | 251 | 6 | PF01094 | |
| Domain | Kelch | 1.22e-05 | 58 | 251 | 7 | SM00612 | |
| Domain | PROTEIN_KINASE_DOM | PDGFRA TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 ADCK5 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 1.22e-05 | 493 | 251 | 20 | PS50011 |
| Domain | Peripla_BP_I | 1.25e-05 | 39 | 251 | 6 | IPR028082 | |
| Domain | Cadherin_C | 1.80e-05 | 25 | 251 | 5 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.80e-05 | 25 | 251 | 5 | IPR000233 | |
| Domain | - | ADH4 FASN AHCY MDH1B HSD17B3 HSDL2 CBR1 CRYZ SCCPDH FAR2 HSD17B10 | 1.85e-05 | 169 | 251 | 11 | 3.40.50.720 |
| Domain | - | 2.67e-05 | 27 | 251 | 5 | 2.130.10.80 | |
| Domain | Ser/Thr_kinase_AS | TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 STK25 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B | 2.83e-05 | 357 | 251 | 16 | IPR008271 |
| Domain | Prot_kinase_dom | PDGFRA TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 3.66e-05 | 489 | 251 | 19 | IPR000719 |
| Domain | Catenin_binding_dom | 3.84e-05 | 29 | 251 | 5 | IPR027397 | |
| Domain | - | 3.84e-05 | 29 | 251 | 5 | 4.10.900.10 | |
| Domain | AA_TRANSFER_CLASS_2 | 4.66e-05 | 6 | 251 | 3 | PS00599 | |
| Domain | Aminotrans_II_pyridoxalP_BS | 4.66e-05 | 6 | 251 | 3 | IPR001917 | |
| Domain | Kinase-like_dom | PDGFRA TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 KIT STK25 ADCK5 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 MAP3K21 TSSK1B PLK4 | 4.70e-05 | 542 | 251 | 20 | IPR011009 |
| Domain | Pkinase | TSSK2 WNK1 CDKL5 CSNK1A1L CSNK1G1 SIK2 TSSK3 STK25 MKNK1 PIM3 CSNK1E PRKAA1 PRKAA2 PRKD1 TSSK1B PLK4 | 6.16e-05 | 381 | 251 | 16 | PF00069 |
| Domain | BTB | 7.05e-05 | 131 | 251 | 9 | PF00651 | |
| Domain | - | 9.84e-05 | 35 | 251 | 5 | 3.90.1150.10 | |
| Domain | Cadherin_CS | 1.12e-04 | 109 | 251 | 8 | IPR020894 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 1.13e-04 | 36 | 251 | 5 | IPR015422 | |
| Domain | Gal_Oxase/kelch_b-propeller | 1.38e-04 | 59 | 251 | 6 | IPR011043 | |
| Domain | CADHERIN_1 | 1.45e-04 | 113 | 251 | 8 | PS00232 | |
| Domain | Cadherin | 1.45e-04 | 113 | 251 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 1.54e-04 | 114 | 251 | 8 | PS50268 | |
| Domain | - | 1.54e-04 | 114 | 251 | 8 | 2.60.40.60 | |
| Domain | Cyclophilin-type_PPIase | 1.59e-04 | 21 | 251 | 4 | IPR024936 | |
| Domain | CA | 1.63e-04 | 115 | 251 | 8 | SM00112 | |
| Domain | - | 1.67e-04 | 39 | 251 | 5 | 3.40.640.10 | |
| Domain | Cadherin-like | 1.73e-04 | 116 | 251 | 8 | IPR015919 | |
| Domain | SecY_su_dom | 1.80e-04 | 2 | 251 | 2 | IPR023201 | |
| Domain | CORTACTIN | 1.80e-04 | 2 | 251 | 2 | PS51090 | |
| Domain | S-AdoMet_synt_N | 1.80e-04 | 2 | 251 | 2 | PF00438 | |
| Domain | SECY_1 | 1.80e-04 | 2 | 251 | 2 | PS00755 | |
| Domain | SECY_2 | 1.80e-04 | 2 | 251 | 2 | PS00756 | |
| Domain | - | 1.80e-04 | 2 | 251 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 1.80e-04 | 2 | 251 | 2 | IPR019561 | |
| Domain | SecY_CS | 1.80e-04 | 2 | 251 | 2 | IPR030659 | |
| Domain | SAR1 | 1.80e-04 | 2 | 251 | 2 | PS51422 | |
| Domain | S-AdoMet_synthetase | 1.80e-04 | 2 | 251 | 2 | IPR002133 | |
| Domain | AdenylateSensor | 1.80e-04 | 2 | 251 | 2 | PF16579 | |
| Domain | Plug_translocon | 1.80e-04 | 2 | 251 | 2 | PF10559 | |
| Domain | AMPK_C | 1.80e-04 | 2 | 251 | 2 | IPR032270 | |
| Domain | S-AdoMet_synt_M | 1.80e-04 | 2 | 251 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 1.80e-04 | 2 | 251 | 2 | PF02773 | |
| Domain | NLGN4 | 1.80e-04 | 2 | 251 | 2 | IPR030025 | |
| Domain | SecY | 1.80e-04 | 2 | 251 | 2 | PF00344 | |
| Domain | ADOMET_SYNTHASE_CS | 1.80e-04 | 2 | 251 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 1.80e-04 | 2 | 251 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 1.80e-04 | 2 | 251 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_central | 1.80e-04 | 2 | 251 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 1.80e-04 | 2 | 251 | 2 | IPR022628 | |
| Domain | Small_GTPase_SAR1 | 1.80e-04 | 2 | 251 | 2 | IPR006687 | |
| Domain | - | 1.80e-04 | 2 | 251 | 2 | 1.10.45.10 | |
| Domain | HS1_rep | 1.80e-04 | 2 | 251 | 2 | PF02218 | |
| Domain | Hs1_Cortactin | 1.80e-04 | 2 | 251 | 2 | IPR003134 | |
| Domain | ADOMET_SYNTHASE_1 | 1.80e-04 | 2 | 251 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 1.80e-04 | 2 | 251 | 2 | PS00377 | |
| Domain | SecY/SEC61-alpha | 1.80e-04 | 2 | 251 | 2 | IPR002208 | |
| Domain | Pro_isomerase | 1.93e-04 | 22 | 251 | 4 | PF00160 | |
| Domain | Cyclophilin-type_PPIase_dom | 1.93e-04 | 22 | 251 | 4 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 1.93e-04 | 22 | 251 | 4 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 1.93e-04 | 22 | 251 | 4 | PS50072 | |
| Domain | - | 1.93e-04 | 22 | 251 | 4 | 2.40.100.10 | |
| Domain | CSA_PPIASE_1 | 1.93e-04 | 22 | 251 | 4 | PS00170 | |
| Domain | Cadherin | 1.95e-04 | 118 | 251 | 8 | IPR002126 | |
| Domain | PyrdxlP-dep_Trfase | 2.13e-04 | 41 | 251 | 5 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 2.13e-04 | 41 | 251 | 5 | IPR015421 | |
| Domain | BTB | 3.21e-04 | 160 | 251 | 9 | PS50097 | |
| Domain | - | 5.35e-04 | 3 | 251 | 2 | 2.70.98.20 | |
| Domain | Cu_amine_oxidase_N3 | 5.35e-04 | 3 | 251 | 2 | IPR015802 | |
| Domain | Cu_amine_oxidase_N2 | 5.35e-04 | 3 | 251 | 2 | IPR015800 | |
| Domain | Glyco_hydro_15/PHK | 5.35e-04 | 3 | 251 | 2 | IPR011613 | |
| Domain | PHK_A/B_su | 5.35e-04 | 3 | 251 | 2 | IPR008734 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | AOC1 PDGFRA MAT1A NRXN3 NLGN4X CSAD SCN5A AHCY SYT1 NLGN2 KIT KYNU GRIA1 GRIA2 NLGN1 GRIN2B CBR1 PRKAA1 PRKAA2 PAH CNTNAP2 GRIP2 CTTN | 1.59e-09 | 367 | 196 | 23 | M48346 |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 1.08e-07 | 18 | 196 | 6 | M48098 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.18e-05 | 56 | 196 | 7 | M27616 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.77e-05 | 87 | 196 | 8 | M27617 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | KCNK9 NRXN3 NLGN4X SLC17A7 SYT1 NLGN2 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B PRKAA1 PRKAA2 GRIP2 | 6.17e-05 | 411 | 196 | 17 | M735 |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 6.54e-05 | 98 | 196 | 8 | M39830 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 7.33e-05 | 32 | 196 | 5 | MM15326 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 8.54e-05 | 33 | 196 | 5 | M39875 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | KCNK9 NRXN3 NLGN4X SLC17A7 SYT1 NLGN2 NLGN4Y GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIP2 | 2.50e-04 | 335 | 196 | 14 | MM14503 |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 2.85e-04 | 121 | 196 | 8 | M39823 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 2.96e-04 | 10 | 196 | 3 | M10272 | |
| Pathway | KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION | 2.96e-04 | 10 | 196 | 3 | M47939 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.30e-04 | 67 | 196 | 6 | MM15327 | |
| Pathway | WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS | 4.02e-04 | 11 | 196 | 3 | M39741 | |
| Pathway | WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING | 4.52e-04 | 71 | 196 | 6 | M39395 | |
| Pubmed | TANC2 MORN4 MYCBP2 HMGCS1 MCCC2 MAGI2 CDKL5 AP3S1 NUFIP2 SYT1 ANKRD28 VDAC1 FLII CAD DIRAS1 GRIA1 GRIA2 GRIN2B PPIA OPA1 STT3B TENM4 CSNK1E IGHMBP2 CNTNAP2 HSD17B10 CRYBG3 CTTN GFM1 NDRG4 DIRAS2 | 4.50e-10 | 1139 | 256 | 31 | 36417873 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 1.14e-09 | 8 | 256 | 5 | 30871858 | |
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 1.14e-09 | 8 | 256 | 5 | 8163463 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 2.56e-09 | 9 | 256 | 5 | 9051806 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MAT2A ETF1 MCCC2 FASN SARS1 AHCY FGD5 CHST2 SEC61A1 VDAC1 FLII KIF23 CAD DSC1 HSDL2 PPIL4 NUP214 THOC2 PPIA SAR1A CBR1 OPA1 SLC2A1 STT3B LIG3 PAXBP1 CSNK1E PRKAA2 HSD17B10 CTTN SRRM2 GFM1 TOP2B | 6.59e-09 | 1425 | 256 | 33 | 30948266 |
| Pubmed | 9.26e-09 | 11 | 256 | 5 | 26403076 | ||
| Pubmed | 9.26e-09 | 11 | 256 | 5 | 32973045 | ||
| Pubmed | 1.43e-08 | 5 | 256 | 4 | 8288598 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 1.43e-08 | 5 | 256 | 4 | 10996085 | |
| Pubmed | 1.43e-08 | 5 | 256 | 4 | 37865312 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.81e-08 | 24 | 256 | 6 | 35746896 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 2.55e-08 | 13 | 256 | 5 | 20859245 | |
| Pubmed | 4.25e-08 | 6 | 256 | 4 | 21838267 | ||
| Pubmed | 4.25e-08 | 6 | 256 | 4 | 29724786 | ||
| Pubmed | 5.88e-08 | 15 | 256 | 5 | 18227507 | ||
| Pubmed | INPP1 MAGI2 NRXN3 SLC17A7 NLGN2 GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B PAH CNTNAP2 | 5.99e-08 | 300 | 256 | 14 | 19086053 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 9.86e-08 | 7 | 256 | 4 | 9016303 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 9.86e-08 | 7 | 256 | 4 | 9651535 | |
| Pubmed | 9.86e-08 | 7 | 256 | 4 | 1310861 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MAT2A LYPLA2 ETF1 HMGCS1 ITGAM WNK1 TXNRD1 FASN AP3S1 AGL AHCY OCIAD2 SEC61A1 PLOD1 HSPA1L FLNC KIF23 PDPR DSC1 SPTLC2 NUP214 CBR1 OPA1 SLC2A1 CRYZ SCCPDH PRKAA1 HSD17B10 CTTN AHNAK2 | 1.10e-07 | 1367 | 256 | 30 | 32687490 |
| Pubmed | IgSF21 promotes differentiation of inhibitory synapses via binding to neurexin2α. | 1.65e-07 | 18 | 256 | 5 | 28864826 | |
| Pubmed | Control of excitatory and inhibitory synapse formation by neuroligins. | 1.96e-07 | 8 | 256 | 4 | 15681343 | |
| Pubmed | TTC39B FASN NUFIP2 FGD5 SEC61A1 PLOD1 VDAC1 SEL1L FLII CAD DSC1 HSDL2 NUP214 ECE1 PPIA TRIM16 ADGB LIG3 PPIL1 GRIP2 HCLS1 | 2.32e-07 | 754 | 256 | 21 | 35906200 | |
| Pubmed | TANC2 MYCBP2 ETF1 MAGI2 CSNK1A1L NUFIP2 SYT1 ANKRD28 NLGN2 FLII KIF23 CAD MSANTD2 GRIA1 GRIA2 GRIK2 GRIN2B PPIA OPA1 FRY PRKD1 CTTN TNR CDH11 | 2.37e-07 | 963 | 256 | 24 | 28671696 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MCCC2 PTER PHKA1 PHKA2 CSNK1A1L NUFIP2 AHCY SIK2 PLOD1 STK25 GRIA2 SAR1A EML3 STT3B MKNK1 TRIM16 CSNK1E PRKAA1 PRKAA2 PRKD1 CTTN MAP3K21 PLK4 | 3.35e-07 | 910 | 256 | 23 | 36736316 |
| Pubmed | 3.51e-07 | 9 | 256 | 4 | 34100982 | ||
| Pubmed | 3.51e-07 | 9 | 256 | 4 | 9278515 | ||
| Pubmed | Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. | 3.94e-07 | 3 | 256 | 3 | 22722203 | |
| Pubmed | Small GTPases SAR1A and SAR1B regulate the trafficking of the cardiac sodium channel Nav1.5. | 3.94e-07 | 3 | 256 | 3 | 30251687 | |
| Pubmed | Distinct Subunit Domains Govern Synaptic Stability and Specificity of the Kainate Receptor. | 3.94e-07 | 3 | 256 | 3 | 27346345 | |
| Pubmed | RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue. | 3.94e-07 | 3 | 256 | 3 | 7523595 | |
| Pubmed | 3.94e-07 | 3 | 256 | 3 | 10358037 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 3.94e-07 | 3 | 256 | 3 | 21282647 | |
| Pubmed | 5.43e-07 | 41 | 256 | 6 | 23676014 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MAT2A LYPLA2 ETF1 MCCC2 WNK1 PTER TXNRD1 FASN AP3S1 SARS1 AGL AHCY PLOD1 VDAC1 FLII CAD HSDL2 PPIA CBR1 OPA1 PAXBP1 FRG1 PRKAA1 PPIL1 HSD17B10 CTTN SRRM2 TOP2B AHNAK2 | 7.34e-07 | 1415 | 256 | 29 | 28515276 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 MYCBP2 WNK1 RHPN1 LIME1 FASN FAT1 CSAD SCN5A NLGN2 HERC1 MCF2L RGL2 D2HGDH FLII FLNC DIRAS1 AOC2 AMBRA1 NUP214 ECE1 EML3 SLC2A1 PIM3 AHNAK2 | 7.79e-07 | 1105 | 256 | 25 | 35748872 |
| Pubmed | 9.09e-07 | 11 | 256 | 4 | 29490264 | ||
| Pubmed | MYCBP2 WNK1 DSCAML1 SIK2 ANKRD28 SLC9A8 TTC7A TENM4 KDM2A GRIP2 NDRG4 | 1.01e-06 | 225 | 256 | 11 | 12168954 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | GALC MCCC2 TXNRD1 LDHD ADHFE1 FASN SARS1 MRPL16 ALAS2 D2HGDH KYNU VDAC1 PDPR HSDL2 SPTLC2 ADCK5 ACOT1 OPA1 SCCPDH HSD17B10 ELN GFM1 SLC25A31 HSPB7 | 1.04e-06 | 1047 | 256 | 24 | 18614015 |
| Pubmed | The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. | 1.16e-06 | 73 | 256 | 7 | 19027726 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 1.20e-06 | 26 | 256 | 5 | 34848499 | |
| Pubmed | 1.36e-06 | 12 | 256 | 4 | 22102170 | ||
| Pubmed | 1.36e-06 | 12 | 256 | 4 | 11891216 | ||
| Pubmed | 1.57e-06 | 4 | 256 | 3 | 9619499 | ||
| Pubmed | Cortactin regulates endo-lysosomal sorting of AMPARs via direct interaction with GluA2 subunit. | 1.57e-06 | 4 | 256 | 3 | 29515177 | |
| Pubmed | 1.57e-06 | 4 | 256 | 3 | 10781952 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 1.57e-06 | 4 | 256 | 3 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 1.57e-06 | 4 | 256 | 3 | 22671294 | |
| Pubmed | 1.57e-06 | 4 | 256 | 3 | 16077734 | ||
| Pubmed | Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders. | 1.95e-06 | 13 | 256 | 4 | 29488136 | |
| Pubmed | 2.96e-06 | 203 | 256 | 10 | 35012549 | ||
| Pubmed | MYCBP2 ENTR1 MCCC2 FCSK SARS1 AGL ANKRD28 SEC61A1 PLOD1 STK25 SPTLC2 AMBRA1 NUP214 OPA1 SLC2A1 SEC61A2 PANK4 | 3.08e-06 | 606 | 256 | 17 | 36538041 | |
| Pubmed | KLHL29 MAGI2 FCSK CDH20 LIPG CSAD SYT1 KLHL1 GRIA1 GRIK2 ECE1 GPC6 PKHD1L1 CUTC TENM4 PANK4 CNTNAP2 PRKD1 FHDC1 HAS2 | 3.08e-06 | 814 | 256 | 20 | 23251661 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | GALNT2 MCCC2 FASN SARS1 AGL AHCY PLOD1 VDAC1 PPIA OPA1 SLC2A1 STT3B HSD17B10 AHNAK2 | 3.52e-06 | 422 | 256 | 14 | 27342126 |
| Pubmed | 3.67e-06 | 15 | 256 | 4 | 33833667 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 28939043 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 18358623 | ||
| Pubmed | Transsynaptic Modulation of Kainate Receptor Functions by C1q-like Proteins. | 3.90e-06 | 5 | 256 | 3 | 27133466 | |
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 3.90e-06 | 5 | 256 | 3 | 9593973 | |
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 3.90e-06 | 5 | 256 | 3 | 23076118 | |
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 3.90e-06 | 5 | 256 | 3 | 1717158 | |
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 3.90e-06 | 5 | 256 | 3 | 15620359 | |
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 3.90e-06 | 5 | 256 | 3 | 18793656 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 12223554 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 3.90e-06 | 5 | 256 | 3 | 18923512 | |
| Pubmed | Heteromer formation of delta2 glutamate receptors with AMPA or kainate receptors. | 3.90e-06 | 5 | 256 | 3 | 12573530 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 28228252 | ||
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 3.90e-06 | 5 | 256 | 3 | 29058671 | |
| Pubmed | GALNT2 MYCBP2 MAT2A MCCC2 WNK1 FASN FAT1 GLB1 NUFIP2 AHCY SEC61A1 PLOD1 STK25 SEL1L KIF23 CAD ACOT1 NUP214 ECE1 PPIA SLC2A1 STT3B PRCP SAR1B KDM2A SRRM2 | 4.24e-06 | 1297 | 256 | 26 | 33545068 | |
| Pubmed | 5.38e-06 | 60 | 256 | 6 | 32027825 | ||
| Pubmed | 5.96e-06 | 93 | 256 | 7 | 27215380 | ||
| Pubmed | 6.33e-06 | 17 | 256 | 4 | 32185508 | ||
| Pubmed | MAT2A ETF1 HMGCS1 MCCC2 FASN SARS1 NUFIP2 AHCY ANKRD28 SEC61A1 FLII KIF23 CAD NUP214 THOC2 PPIA OPA1 SEC61A2 LIG3 PAXBP1 CSNK1E IGHMBP2 HSD17B10 CTTN SRRM2 | 6.55e-06 | 1247 | 256 | 25 | 27684187 | |
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 20418887 | ||
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 20729278 | ||
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 18922769 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 7.76e-06 | 6 | 256 | 3 | 28714086 | |
| Pubmed | A Functional Link between AMPK and Orexin Mediates the Effect of BMP8B on Energy Balance. | 7.76e-06 | 6 | 256 | 3 | 27524625 | |
| Pubmed | Neto1 is an auxiliary subunit of native synaptic kainate receptors. | 7.76e-06 | 6 | 256 | 3 | 21734292 | |
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 10331083 | ||
| Pubmed | Physiological role for casein kinase 1 in glutamatergic synaptic transmission. | 7.76e-06 | 6 | 256 | 3 | 16014721 | |
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 19816407 | ||
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 21365123 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 7.76e-06 | 6 | 256 | 3 | 8576240 | |
| Pubmed | 8.09e-06 | 18 | 256 | 4 | 34455539 | ||
| Pubmed | TANC2 IL16 ETF1 MAGI2 CDKL5 FASN CSNK1A1L SARS1 NUFIP2 SLC17A7 SYT1 VDAC1 FLII FLNC CAD GRIA1 GRIA2 GRIN2B CBR1 OPA1 SLC2A1 HAPLN1 TENM4 PRKAA1 CTTN TNR DIRAS2 | 8.27e-06 | 1431 | 256 | 27 | 37142655 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYCBP2 LYPLA2 SARS1 NUFIP2 PLOD1 FLII FLNC PPIL4 CBR1 STT3B SCCPDH PRKAA1 PPIL1 KDM2A HSD17B10 CTTN TOP2B AHNAK2 | 8.28e-06 | 724 | 256 | 18 | 36232890 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYCBP2 MAT2A MCCC2 FASN AP3S1 AHCY ANKRD28 PLOD1 HSPA1L FLII FLNC KIF23 CAD DSC1 SPTLC2 PPIL4 AMBRA1 NUP214 PPIA CBR1 SLC2A1 LIG3 KDM2A SRRM2 TOP2B AHNAK2 | 8.94e-06 | 1353 | 256 | 26 | 29467282 |
| Pubmed | CSMD3 KLHL29 MAGI2 NUFIP2 MCF2L NUP214 NLGN1 ZSWIM6 OPA1 TENM4 DAAM2 SRRM2 VPS13B | 1.18e-05 | 407 | 256 | 13 | 12693553 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MAT2A FASN CSNK1A1L AGL ANKRD28 SEC61A1 PLOD1 SEL1L FLNC SPTLC2 PPIL4 AMBRA1 NUP214 OPA1 STT3B CSNK1E PRKAA1 PRKAA2 CTTN SRRM2 GFM1 | 1.27e-05 | 974 | 256 | 21 | 28675297 |
| Pubmed | Characterization of cadherins expressed by murine thymocytes. | 1.35e-05 | 7 | 256 | 3 | 8620560 | |
| Pubmed | 1.35e-05 | 7 | 256 | 3 | 19342380 | ||
| Pubmed | 1.35e-05 | 7 | 256 | 3 | 17428973 | ||
| Pubmed | The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver. | 1.35e-05 | 7 | 256 | 3 | 25088745 | |
| Pubmed | 1.35e-05 | 7 | 256 | 3 | 8879495 | ||
| Pubmed | CKAMP44: a brain-specific protein attenuating short-term synaptic plasticity in the dentate gyrus. | 1.35e-05 | 7 | 256 | 3 | 20185686 | |
| Pubmed | Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. | 1.35e-05 | 7 | 256 | 3 | 21558424 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FASN SCN5A NUFIP2 AHCY HSPA1L VDAC1 FLNC CAD DSC1 PPIA OPA1 HSD17B10 CTTN SRRM2 | 1.40e-05 | 477 | 256 | 14 | 31300519 |
| Pubmed | WNK1 PHKA1 CSNK1A1L GLB1 MRPL16 AHCY STK25 SEL1L CAD HSDL2 SPTLC2 ACOT1 SAR1A STT3B SCCPDH PRKAA2 PRKD1 | 1.54e-05 | 686 | 256 | 17 | 28380382 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYCBP2 MAT2A HMGCS1 PHKA1 PHKA2 FASN SARS1 AGL NUFIP2 AHCY HSPA1L VDAC1 FLII FLNC CAD PPIA CBR1 LIG3 PANK4 HSD17B10 SLFN11 CTTN SRRM2 | 1.59e-05 | 1149 | 256 | 23 | 35446349 |
| Interaction | GRIK2 interactions | 1.04e-07 | 32 | 249 | 7 | int:GRIK2 | |
| Interaction | CDKL5 interactions | KLHL20 CDKL5 MGMT NUFIP2 GRIA2 GRIN2B PPIA CSNK1E IGHMBP2 SAR1B | 1.41e-06 | 113 | 249 | 10 | int:CDKL5 |
| Interaction | GRID2 interactions | 6.13e-06 | 22 | 249 | 5 | int:GRID2 | |
| Interaction | FLNC interactions | TANC2 MAT2A HMGCS1 WNK1 FASN AP3S1 AHCY ANKRD28 FGD5 FLNC PPIA HSD17B10 HSPB7 | 7.37e-06 | 234 | 249 | 13 | int:FLNC |
| Interaction | DLG2 interactions | 8.61e-06 | 83 | 249 | 8 | int:DLG2 | |
| Interaction | ELFN1 interactions | 2.79e-05 | 15 | 249 | 4 | int:ELFN1 | |
| Interaction | LYSMD4 interactions | 3.63e-05 | 6 | 249 | 3 | int:LYSMD4 | |
| Cytoband | 14q31 | 1.40e-05 | 9 | 256 | 3 | 14q31 | |
| GeneFamily | Kelch like|BTB domain containing | 1.12e-06 | 42 | 148 | 6 | 617 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.58e-06 | 134 | 148 | 9 | 861 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.91e-06 | 13 | 148 | 4 | 1186 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 2.91e-06 | 76 | 148 | 7 | 743 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 5.31e-06 | 5 | 148 | 3 | 1199 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 1.52e-05 | 19 | 148 | 4 | 909 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 3.95e-04 | 4 | 148 | 2 | 1200 | |
| GeneFamily | Solute carriers | SLC35C1 SLC17A7 SLC9A8 SLC17A4 SLC6A15 SLC47A2 SLC2A1 SLC6A7 SLC45A2 SLC2A11 SLC25A31 | 4.15e-04 | 395 | 148 | 11 | 752 |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 7.99e-04 | 51 | 148 | 4 | 870 | |
| GeneFamily | Glypicans | 9.77e-04 | 6 | 148 | 2 | 572 | |
| GeneFamily | PDZ domain containing | 1.58e-03 | 152 | 148 | 6 | 1220 | |
| GeneFamily | Alcohol dehydrogenases | 1.80e-03 | 8 | 148 | 2 | 397 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | BTBD6 MYCBP2 SYTL2 PDZD7 KLHL29 SYT1 MCF2L KIT GRIA1 GRIA2 SLC6A15 GRIK2 FRY FAR2 GRIP2 NDRG4 DIRAS2 | 2.06e-06 | 450 | 253 | 17 | M39072 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | MYCBP2 SYTL2 PDZD7 CSMD2 CSMD3 CDKL5 NRXN3 CSAD SYT1 MCF2L KLHL1 GRIA1 GRIA2 GRIK2 NLGN1 FRY TENM4 FAR2 CNTNAP2 GRIP2 NDRG4 | 5.36e-06 | 703 | 253 | 21 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 MYCBP2 SYTL2 PDZD7 CSMD2 CSMD3 DSCAML1 MAGI2 NRXN3 NLGN4X CSAD SYT1 HERC1 MCF2L GRIA1 GRIA2 SLC6A15 GRIK1 GRIK2 NLGN1 FRY PRKAA2 CNTNAP2 GRIP2 NDRG4 DIRAS2 AHNAK2 | 1.01e-05 | 1106 | 253 | 27 | M39071 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | BTBD6 GALNT2 SYTL2 HMGCS1 CDKL5 OCIAD2 FLNC ACOT1 DPP3 ECE1 SLC2A1 LIG3 KLHL5 TOB1 FHDC1 THNSL2 HSPB7 AHNAK2 | 1.89e-05 | 589 | 253 | 18 | M45662 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | GALC HMGCS1 CSMD3 FAT1 NLGN4X LIPG GPC4 FLNC HSDL2 NLGN4Y GRIA1 NLGN1 THOC2 PRCP PRKAA2 GPR137B ELN HAS2 | 2.42e-05 | 600 | 253 | 18 | M39055 |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP | 2.66e-05 | 200 | 253 | 10 | M5003 | |
| Coexpression | MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN | 4.46e-05 | 21 | 253 | 4 | M398 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | SPTLC3 SYTL2 LIME1 FAT1 NRXN3 PKHD1 SIK2 DPP4 SPTLC2 GPC6 PPIA CRYZ PRKAA2 FHDC1 | 4.64e-05 | 407 | 253 | 14 | M2214 |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | CAPN9 SYTL2 MCCC2 ITGA7 SVEP1 FASN AGL CSAD UGT2B15 SYT1 MCF2L HSDL2 SPTLC2 GRIA2 FRY SCCPDH TOB1 CNTNAP2 CHRD | 5.46e-05 | 699 | 253 | 19 | M4960 |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP | ITGAM PHKA1 SLC17A7 KIT DPP4 SPTLC2 ZSWIM6 HAPLN1 GPR137B ELN CDH11 | 5.82e-05 | 265 | 253 | 11 | M2255 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#5_top-relative-expression-ranked_500 | GALC PIPOX PTER NXPE3 C8A KYNU DPP4 SLC6A15 ACOT1 PRKAA2 CDH6 | 2.64e-07 | 125 | 249 | 11 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_500 | GALC PIPOX PTER NXPE3 PKHD1 UGT2B15 UGT2B17 C8A KYNU DPP4 SLC6A15 ACOT1 GPC6 PRKAA2 PAH GPR137B MAP3K21 CDH6 | 8.71e-07 | 389 | 249 | 18 | gudmap_developingKidney_e15.5_Proximal Tubules_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_1000 | GALC PIPOX PTER CSAD GPC4 UGT2B17 KYNU DPP4 ACOT1 CRYZ GPR137B CDH6 | 9.95e-07 | 173 | 249 | 12 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_1000 | GALC AOC1 PIPOX PTER RHPN1 FCSK ADHFE1 GLB1 CSAD GPC4 PKHD1 UGT2B15 UGT2B17 KYNU DPP4 ACOT1 CRYZ TM2D2 PAH GPR137B GRIP2 THNSL2 MAP3K21 CDH6 AHNAK2 | 6.23e-06 | 784 | 249 | 25 | gudmap_developingKidney_e15.5_early proxim tubul_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | GALC MYCBP2 PIPOX PTER NXPE3 ADHFE1 CSAD GPC4 PKHD1 UGT2B15 UGT2B17 C8A KYNU DPP4 SLC6A15 ACOT1 GPC6 PAXBP1 PRKAA2 PAH GPR137B THNSL2 MAP3K21 CDH6 | 1.08e-05 | 758 | 249 | 24 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#4_top-relative-expression-ranked_200 | 2.83e-05 | 51 | 249 | 6 | gudmap_developingKidney_e15.5_Proximal Tubules_200_k4 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000 | PXMP4 SPTLC3 CYP2A13 GALC GALM PIPOX MCCC2 PTER ADHFE1 GLB1 PKHD1 UGT2B15 ABCG2 KYNU DPP4 DPYD HSDL2 SLC6A15 CUTC CRYZ SAR1B PRKAA2 PAH GPR137B THNSL2 | 3.01e-05 | 861 | 249 | 25 | gudmap_kidney_adult_RenalCortexMixed_Std_1000 |
| CoexpressionAtlas | cerebral cortex | KLHL2 CSMD2 CSMD3 KCNK9 DSCAML1 MAGI2 RHPN1 CDKL5 NRXN3 CDH20 NLGN4X SLC17A7 SYT1 NLGN2 NOVA2 KLHL1 DIRAS1 GRIA1 GRIA2 SLC6A15 GRIK1 GRIK2 KCNK12 GRIK4 NLGN1 GRIN2B SLC6A7 SEC61A2 CNTNAP2 RXFP1 TNR CDH9 NDRG4 DIRAS2 | 6.51e-05 | 1428 | 249 | 34 | cerebral cortex |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_500 | 1.14e-04 | 22 | 249 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#5_top-relative-expression-ranked_1000 | GALC PIPOX PTER NXPE3 CSAD C8A KYNU DPP4 SLC6A15 ACOT1 PRKAA2 GPR137B | 1.24e-04 | 280 | 249 | 12 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | KLHL2 PDGFRA SVEP1 NRXN3 ALAS2 CAPS2 HERC1 SEC61A1 PLOD1 COL1A2 DPP4 DPYD GRIK1 ECE1 GPC6 THOC2 TENM4 ELN HAS2 CTTN MAP3K21 AHNAK2 | 1.67e-04 | 790 | 249 | 22 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#4_top-relative-expression-ranked_1000 | PTER ADHFE1 CSAD GPC4 PKHD1 UGT2B15 UGT2B17 PAH GPR137B THNSL2 | 1.74e-04 | 207 | 249 | 10 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_500 | 2.27e-04 | 104 | 249 | 7 | gudmap_developingKidney_e15.5_early proxim tubul_500_k4 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_1000 | CYP2A13 PIPOX PTER LDHD ADHFE1 GPC4 PKHD1 UGT2B15 ABCG2 KYNU DPYD CRYZ PRKAA2 PAH GPR137B | 2.39e-04 | 441 | 249 | 15 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_1000 |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_k-means-cluster#4_top-relative-expression-ranked_500 | PXMP4 CYP2A13 GALM PIPOX PTER LDHD ADHFE1 GPC4 UGT2B15 VDAC1 SAR1A CRYZ PAH THNSL2 | 2.41e-04 | 393 | 249 | 14 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_k4_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_500 | GALC PIPOX PTER ADHFE1 PKHD1 UGT2B15 UGT2B17 KYNU DPP4 ACOT1 PAH GPR137B THNSL2 AHNAK2 | 2.41e-04 | 393 | 249 | 14 | gudmap_developingKidney_e15.5_early proxim tubul_500 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 SPTLC3 KLHL2 DSCAML1 MAGI2 CFAP54 GPC4 PKHD1 NLGN1 SLC45A2 PRKD1 CDH6 CDH9 | 7.20e-11 | 187 | 256 | 13 | c31130fc2f9f882944b2ba366a034a03f051c4b9 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 SPTLC3 DSCAML1 MAGI2 GPC4 PKHD1 KIF23 NLGN1 GPC6 SLC45A2 PRKD1 CDH6 CDH9 | 7.69e-11 | 188 | 256 | 13 | af740fa78542438fdff627ea1f74f4eee43316be |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SPTLC3 KLHL2 DSCAML1 MAGI2 CFAP54 GPC4 PKHD1 NLGN1 GPC6 SLC45A2 PRKD1 CDH6 | 9.24e-10 | 186 | 256 | 12 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-09 | 175 | 256 | 11 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-09 | 175 | 256 | 11 | 445ccb9744a3a9ff37164c532afbe769d306b6c8 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | RASIP1 NRXN3 NLGN4X FGD5 MCF2L NOVA2 ECE1 KLHL5 RXFP1 TNR NDRG4 | 1.23e-08 | 187 | 256 | 11 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-08 | 152 | 256 | 10 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRA SVEP1 FAT1 GPC4 COL1A2 GPC6 PPIC HAPLN1 TENM4 HAS2 CDH11 | 2.22e-08 | 198 | 256 | 11 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | MYCBP2 NRXN3 SYT1 HERC1 VDAC1 GRIA1 GRIA2 GRIN2B SLC6A7 CNTNAP2 NDRG4 | 2.46e-08 | 200 | 256 | 11 | c888fd487990cad482a4ca47601cdebc0ca3f3ce |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA CSMD2 CSMD3 NLGN4X GRIK1 GRIK2 NLGN1 GRIN2B GPC6 FRY TNR | 2.46e-08 | 200 | 256 | 11 | 961858738ce35db8760c8c2e136f8369bc444ccf |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA CSMD2 CSMD3 NLGN4X GRIK1 GRIK2 NLGN1 GRIN2B GPC6 FRY TNR | 2.46e-08 | 200 | 256 | 11 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA CSMD2 CSMD3 NLGN4X GRIK1 GRIK2 NLGN1 GRIN2B GPC6 FRY TNR | 2.46e-08 | 200 | 256 | 11 | cc3409518f8b436ea92deb955e81114b3f410ff7 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA CSMD2 CSMD3 NLGN4X GRIK1 GRIK2 NLGN1 GRIN2B GPC6 FRY TNR | 2.46e-08 | 200 | 256 | 11 | c24a3099e3d96d8b72f6d05286bb355d661a0377 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA CSMD2 CSMD3 NLGN4X GRIK1 GRIK2 NLGN1 GRIN2B GPC6 FRY TNR | 2.46e-08 | 200 | 256 | 11 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA CSMD2 CSMD3 NLGN4X GRIK1 GRIK2 NLGN1 GRIN2B GPC6 FRY TNR | 2.46e-08 | 200 | 256 | 11 | 310cd53db1c137f6af74e6ae682221d7ac27310c |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | DSCAML1 FAT1 CDH20 KIT GRIK1 GRIK2 HAPLN1 CNTNAP2 RXFP1 HAS2 | 2.68e-08 | 157 | 256 | 10 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | DSCAML1 MAGI2 FAT1 CFAP54 GPC4 PKHD1 SLC17A4 NLGN1 MAP3K21 CDH6 | 5.10e-08 | 168 | 256 | 10 | a086c306be430adf0632ba53e98cd8014d2de330 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-08 | 176 | 256 | 10 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.79e-08 | 178 | 256 | 10 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | DSCAML1 MAGI2 FAT1 CFAP54 GPC4 PKHD1 SLC17A4 NLGN1 TENM4 CDH6 | 8.79e-08 | 178 | 256 | 10 | 544379f5a6145429762258d426b876bb36c112f5 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-07 | 183 | 256 | 10 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 189 | 256 | 10 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | GPC4 SYT1 COL1A2 DPYD SLC6A15 GRIK4 SLC47A2 SLC6A7 NDRG4 HSPB7 | 1.54e-07 | 189 | 256 | 10 | 6e83bf855d4771885b60bb8992df2f9b508eef97 |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | GPC4 SYT1 COL1A2 DPYD SLC6A15 GRIK4 SLC47A2 SLC6A7 NDRG4 HSPB7 | 1.54e-07 | 189 | 256 | 10 | cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48 |
| ToppCell | droplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | GPC4 SYT1 COL1A2 DPYD SLC6A15 GRIK4 SLC47A2 SLC6A7 NDRG4 HSPB7 | 1.54e-07 | 189 | 256 | 10 | 102501eee7760d5882dec41ea9d00147b3f4fb73 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-07 | 190 | 256 | 10 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-07 | 191 | 256 | 10 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-07 | 191 | 256 | 10 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-07 | 191 | 256 | 10 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-07 | 191 | 256 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-07 | 192 | 256 | 10 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.78e-07 | 192 | 256 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-07 | 193 | 256 | 10 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-07 | 193 | 256 | 10 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-07 | 194 | 256 | 10 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.06e-07 | 195 | 256 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-07 | 196 | 256 | 10 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 SPTLC3 GALNT2 SYTL2 DSCAML1 FAT1 PKHD1 NLGN1 PRKAA2 PRKD1 | 2.26e-07 | 197 | 256 | 10 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CSMD3 SVEP1 CHST2 COL1A2 DPYD GRIA1 GRIK4 NLGN1 GPC6 CNTNAP2 | 2.26e-07 | 197 | 256 | 10 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-07 | 198 | 256 | 10 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.37e-07 | 198 | 256 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-07 | 198 | 256 | 10 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-07 | 198 | 256 | 10 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ITGA7 CSMD3 SVEP1 KLHL29 COL1A2 NLGN1 GPC6 SLC2A1 DAAM2 CDH11 | 2.48e-07 | 199 | 256 | 10 | 3835452e4848d7f7dd8651c17b746b271ef39688 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRA SVEP1 KLHL29 COL1A2 GRIK2 TENM4 CNTNAP2 DAAM2 HAS2 CDH11 | 2.48e-07 | 199 | 256 | 10 | 6200618e029063486719479c41eaf31798bd13cf |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | TANC2 CDKL5 NRXN3 SYT1 VDAC1 GRIA1 GRIA2 SLC6A15 GRIN2B NDRG4 | 2.48e-07 | 199 | 256 | 10 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | SVEP1 NLGN4X PTPRQ COL1A2 FLNC DIRAS1 NLGN1 PKHD1L1 CDH6 HSPB7 | 2.60e-07 | 200 | 256 | 10 | 553386523fd8f8f36617a0d81032224b7ddce442 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | MYCBP2 CSMD3 NRXN3 SYT1 HERC1 GRIA1 GRIK2 GRIN2B FRY CNTNAP2 | 2.60e-07 | 200 | 256 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-07 | 155 | 256 | 9 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-07 | 156 | 256 | 9 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 160 | 256 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 160 | 256 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-07 | 162 | 256 | 9 | de0fde4310a56dc96bfc134c44d104993526d9bc | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-07 | 167 | 256 | 9 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-07 | 168 | 256 | 9 | b14fd50232887b6dca1f39014d43c6f66e5c3b5c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-07 | 169 | 256 | 9 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-07 | 171 | 256 | 9 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-07 | 172 | 256 | 9 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-07 | 172 | 256 | 9 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 181 | 256 | 9 | 48d28eafbb5f4b141deeb0bf020dfca39e7be7a5 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 181 | 256 | 9 | 0a44781cc34535f061812d1370f748b7bbdef17b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 181 | 256 | 9 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-06 | 182 | 256 | 9 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 182 | 256 | 9 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 182 | 256 | 9 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 183 | 256 | 9 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 183 | 256 | 9 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 183 | 256 | 9 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 184 | 256 | 9 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 186 | 256 | 9 | 055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-06 | 186 | 256 | 9 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-06 | 186 | 256 | 9 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-06 | 186 | 256 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-06 | 187 | 256 | 9 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.43e-06 | 187 | 256 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 187 | 256 | 9 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 187 | 256 | 9 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-06 | 187 | 256 | 9 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.43e-06 | 187 | 256 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-06 | 187 | 256 | 9 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 187 | 256 | 9 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 187 | 256 | 9 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 187 | 256 | 9 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.56e-06 | 189 | 256 | 9 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 189 | 256 | 9 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-06 | 189 | 256 | 9 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 189 | 256 | 9 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 189 | 256 | 9 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.56e-06 | 189 | 256 | 9 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 191 | 256 | 9 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 191 | 256 | 9 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 191 | 256 | 9 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-06 | 191 | 256 | 9 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.85e-06 | 193 | 256 | 9 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 193 | 256 | 9 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.85e-06 | 193 | 256 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.93e-06 | 194 | 256 | 9 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.93e-06 | 194 | 256 | 9 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.93e-06 | 194 | 256 | 9 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.93e-06 | 194 | 256 | 9 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| Computational | Genes in the cancer module 286 | 1.57e-05 | 37 | 160 | 6 | MODULE_286 | |
| Drug | LY339434 | 1.98e-08 | 9 | 253 | 5 | CID006324635 | |
| Drug | Joro spider toxin | 2.16e-08 | 43 | 253 | 8 | CID000119582 | |
| Drug | L-cycloserine | 4.78e-08 | 66 | 253 | 9 | CID000000401 | |
| Drug | willardine | 5.11e-08 | 32 | 253 | 7 | CID000005123 | |
| Drug | prochloraz | ADH4 MAGI2 FASN ACSBG2 ABCG2 DPYD GRIA2 GRIK1 GRIK2 NLGN1 GRIN2B CBR1 PIM3 KLHL5 CSNK1E HSD17B10 | 5.99e-08 | 268 | 253 | 16 | ctd:C045362 |
| Drug | aspartate | USP17L7 WNK1 KCNK9 ADHFE1 AGL SLC17A7 SYT1 KIT PLOD1 KYNU VDAC1 CAD GRIA1 GRIA2 GRIK1 GRIK4 GRIN2B SLC2A1 IGHMBP2 PRKD1 THNSL2 TGS1 | 9.08e-08 | 518 | 253 | 22 | CID000000424 |
| Drug | NS 102 | 1.14e-07 | 22 | 253 | 6 | CID005282252 | |
| Drug | alpha-aminoadipate | 1.17e-07 | 73 | 253 | 9 | CID000000469 | |
| Drug | phenobarbital | CYP2A7 CYP2A13 PIPOX ADHFE1 UGT2B15 UGT2B17 ALAS2 CAD GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 GRIN2B SLC2A1 CRYZ PRKD1 HAS2 | 1.30e-07 | 360 | 253 | 18 | CID000004763 |
| Drug | YM90K | 1.53e-07 | 23 | 253 | 6 | CID005486547 | |
| Drug | gavestinel | 2.63e-07 | 25 | 253 | 6 | CID006450546 | |
| Drug | maltos | B4GALT2 GALC GALM CEL MAT2A MCCC2 ITGAM LDHD ADHFE1 GLB1 FCN1 AGL VDAC1 FLII PDPR SLC2A1 ELN PLK4 | 4.73e-07 | 393 | 253 | 18 | CID000000294 |
| Drug | NADP(H | CYP2A7 CYP2A13 INPP1 PIPOX HMGCS1 ADH4 ADHFE1 FASN GLB1 UGT2B15 UGT2B17 HSD17B3 KYNU DPYD SPTLC2 CBR1 CRYZ SCCPDH FAR2 CSNK1E HAS2 | 5.12e-07 | 527 | 253 | 21 | CID000000930 |
| Drug | philanthotoxin | 6.10e-07 | 45 | 253 | 7 | CID000115201 | |
| Drug | decahydroisoquinoline | 6.44e-07 | 16 | 253 | 5 | CID000097812 | |
| Drug | hydride | CYP2A7 CYP2A13 GALM MAT2A PIPOX HMGCS1 MCCC2 WNK1 ADH4 LDHD ADHFE1 FASN SYT1 HSD17B3 KYNU DPYD SLC9A8 CAD PARP3 GRIN2B CBR1 SLC47A2 CRYZ FAR2 PAH PRKD1 HSD17B10 | 7.34e-07 | 835 | 253 | 27 | CID000000783 |
| Drug | LY293558 | 8.42e-07 | 30 | 253 | 6 | CID000127894 | |
| Drug | spermidine | AOC1 MAT1A MAT2A CSNK1A1L CSNK1G1 AHCY COL1A2 PLCZ1 AOC2 GRIK1 GRIN2B STT3B CSNK1E TOP2B | 1.01e-06 | 253 | 253 | 14 | CID000001102 |
| Drug | 4-methylglutamic acid | 1.03e-06 | 31 | 253 | 6 | CID000005365 | |
| Drug | AC1L1H8N | 1.36e-06 | 3 | 253 | 3 | CID000004023 | |
| Drug | LY354740 | 1.47e-06 | 51 | 253 | 7 | CID000114827 | |
| Drug | 6,7-dinitroquinoxaline | 1.53e-06 | 33 | 253 | 6 | CID002724608 | |
| Drug | LY382884 | 1.67e-06 | 19 | 253 | 5 | CID000656723 | |
| Drug | Quinoxaline | 1.68e-06 | 52 | 253 | 7 | CID000007045 | |
| Drug | performic acid | 1.68e-06 | 52 | 253 | 7 | CID000066051 | |
| Drug | 1m5b | 1.80e-06 | 9 | 253 | 4 | CID000447081 | |
| Drug | Ly294486 | 1.80e-06 | 9 | 253 | 4 | CID005311255 | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A | RABEPK PDGFRA KLHL29 NRXN3 LIPG SLC17A7 SYT1 ACSBG2 MCF2L CSNK1E CNTNAP2 CDH6 | 2.03e-06 | 195 | 253 | 12 | 5980_DN |
| Drug | IDRA 21 | 2.20e-06 | 20 | 253 | 5 | CID000003688 | |
| Drug | spermine | AOC1 MAT1A MAT2A KCNK9 CSNK1A1L CSNK1G1 VDAC1 PLCZ1 PDPR AOC2 GRIA1 GRIA2 GRIK1 GRIN2B STT3B CSNK1E TOP2B | 2.23e-06 | 394 | 253 | 17 | CID000001103 |
| Drug | gacyclidine | 2.61e-06 | 36 | 253 | 6 | CID000176265 | |
| Drug | glutamic acid diethyl ester | 2.61e-06 | 36 | 253 | 6 | CID000073960 | |
| Drug | betaine | MAT1A MAT2A PIPOX WNK1 ADHFE1 AHCY SLC17A7 PLOD1 PDPR PRKD1 ELN TGS1 | 2.64e-06 | 200 | 253 | 12 | CID000000247 |
| Drug | CX546 | 2.87e-06 | 21 | 253 | 5 | CID000002890 | |
| Drug | 3-dimethylaminobenzoic acid | 2.97e-06 | 10 | 253 | 4 | CID000066837 | |
| Drug | Benzoates | 2.97e-06 | 10 | 253 | 4 | ctd:D001565 | |
| Drug | GYKI 52466 | 3.57e-06 | 58 | 253 | 7 | CID000003538 | |
| Drug | L-BMAA | 3.64e-06 | 38 | 253 | 6 | CID000028558 | |
| Drug | GAMs | 3.64e-06 | 38 | 253 | 6 | CID000002935 | |
| Drug | CX516 | 3.67e-06 | 22 | 253 | 5 | CID000148184 | |
| Drug | glucose-6-P | GALM ETF1 PHKA1 PHKA2 LDHD ADHFE1 CSNK1A1L GLB1 AGL CSNK1G1 VDAC1 SLC17A4 SLC2A1 CSNK1E SRRM2 SLC2A11 | 3.78e-06 | 366 | 253 | 16 | CID000000208 |
| Drug | DETC-MeSO | 4.26e-06 | 39 | 253 | 6 | CID003035711 | |
| Drug | D-N-Q | 4.38e-06 | 84 | 253 | 8 | CID000003140 | |
| Drug | YM872 | 4.62e-06 | 11 | 253 | 4 | CID000148200 | |
| Drug | sym 2206 | 4.62e-06 | 11 | 253 | 4 | CID005039877 | |
| Drug | tribromoethanol | 4.65e-06 | 23 | 253 | 5 | CID000006400 | |
| Drug | lanthionamine | 5.38e-06 | 4 | 253 | 3 | CID000070096 | |
| Drug | CGP 39653 | 5.82e-06 | 24 | 253 | 5 | CID006437837 | |
| Drug | hydroxyl radicals | CYP2A7 CYP2A13 GALC AOC1 CEL MYCBP2 INPP1 MAT1A LYPLA2 PIPOX HMGCS1 MCCC2 ADH4 RASIP1 ADHFE1 FASN GLB1 LIPG AGL AHCY SLC17A7 SYT1 KIT PLOD1 KYNU PLCZ1 DPYD CAD PDPR AOC2 PAH PRKD1 HSD17B10 GFM1 | 6.10e-06 | 1341 | 253 | 34 | CID000000961 |
| Drug | Atpa | 6.87e-06 | 12 | 253 | 4 | CID000002252 | |
| Drug | pyridoxal 5'-phosphate | AOC1 MAT2A PHKA1 PHKA2 FASN SLC17A7 SYT1 ALAS2 KYNU SPTLC2 AOC2 PAH THNSL2 LRIT1 | 7.65e-06 | 301 | 253 | 14 | CID000001051 |
| Drug | Naspm | 9.84e-06 | 13 | 253 | 4 | CID000129695 | |
| Drug | L-689,560 | 1.08e-05 | 27 | 253 | 5 | CID000121918 | |
| Drug | butylparaben | MAGI2 FASN UGT2B15 SLC17A7 GRIA2 GRIK2 GRIK4 NLGN1 GRIN2B HSD17B10 | 1.08e-05 | 157 | 253 | 10 | ctd:C038091 |
| Drug | C-PP | 1.30e-05 | 28 | 253 | 5 | CID000001228 | |
| Drug | aptiganel | 1.30e-05 | 28 | 253 | 5 | CID000060839 | |
| Drug | 2-butenedioate | MCCC2 ADHFE1 SARS1 LIPG NOVA2 GRIA1 GRIA2 GRIK1 GRIK4 GRIN2B CRYZ PRKD1 | 1.31e-05 | 234 | 253 | 12 | CID000000723 |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HT_HG-U133A | IL16 FCN1 ACSBG2 C8A MCF2L PARP3 GRIA1 GRIK2 KCNK12 HAPLN1 ADGB | 1.36e-05 | 197 | 253 | 11 | 6705_UP |
| Drug | M - 362 | 1.37e-05 | 14 | 253 | 4 | CID000025457 | |
| Drug | nitrophenol | 1.37e-05 | 14 | 253 | 4 | CID000006947 | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A | PXMP4 TANC2 SVEP1 ACSBG2 SEL1L PARP3 NUP214 GRIN2B ECE1 IGHMBP2 CDH6 | 1.43e-05 | 198 | 253 | 11 | 7390_UP |
| Drug | avermectin | 1.47e-05 | 48 | 253 | 6 | CID006450460 | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; HL60; HT_HG-U133A | CAPN9 PDGFRA SYTL2 LIPG SCN5A SLC17A7 SEL1L AOC2 SLC17A4 ECE1 IGHMBP2 | 1.50e-05 | 199 | 253 | 11 | 3089_UP |
| Drug | N-methyl-DL-aspartic acid | MAGI2 FAT1 CSAD SLC17A7 PLOD1 KYNU FLII GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NUP214 NLGN1 GRIN2B ZSWIM6 SLC2A1 IGHMBP2 PAH PRKD1 GRIP2 | 1.51e-05 | 655 | 253 | 21 | CID000004376 |
| Drug | aniracetam | 1.53e-05 | 130 | 253 | 9 | CID000002196 | |
| Drug | AC1NUW3V | 1.56e-05 | 29 | 253 | 5 | CID005462126 | |
| Drug | ketobemidone | 1.56e-05 | 29 | 253 | 5 | CID000010101 | |
| Drug | 5,7-dichlorokynurenic acid | 1.66e-05 | 49 | 253 | 6 | CID000001779 | |
| Drug | DL-Serine | ZBTB48 PIPOX SARS1 STK25 SPTLC2 GRIA1 GRIA2 GRIK1 GRIK4 GRIN2B SRRM2 | 1.81e-05 | 203 | 253 | 11 | CID000000617 |
| Drug | thiokynurenic acid | 1.85e-05 | 15 | 253 | 4 | CID003035667 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 1.85e-05 | 30 | 253 | 5 | CID000001226 | |
| Drug | GYKI 53655 | 1.85e-05 | 30 | 253 | 5 | CID000126757 | |
| Drug | AC1L32TU | 1.85e-05 | 30 | 253 | 5 | CID000107831 | |
| Drug | AC1L1FA8 | 1.87e-05 | 50 | 253 | 6 | CID000003150 | |
| Drug | NPC 12626 | 2.18e-05 | 31 | 253 | 5 | CID000108099 | |
| Drug | LY235959 | 2.18e-05 | 31 | 253 | 5 | CID000131938 | |
| Drug | eliprodil | 2.18e-05 | 31 | 253 | 5 | CID000060703 | |
| Drug | 2-amino-3-phosphonopropionic acid | 2.19e-05 | 76 | 253 | 7 | CID000003857 | |
| Drug | UDP-glucose | B4GALT2 GALC GALM GALNT2 SLC35C1 ADHFE1 GLB1 AGL UGT2B15 UGT2B17 HAS2 VPS13B | 2.24e-05 | 247 | 253 | 12 | CID000001166 |
| Drug | aminopyrine | CYP2A7 CYP2A13 PIPOX ADHFE1 UGT2B15 UGT2B17 ALAS2 CNTNAP2 SLC45A2 HAS2 | 2.26e-05 | 171 | 253 | 10 | CID000006009 |
| Drug | AC1L1EKQ | 2.35e-05 | 52 | 253 | 6 | CID000002834 | |
| Drug | dl-Lysine | PIPOX WNK1 CSNK1A1L GLB1 CSNK1G1 PLOD1 SLC6A15 SCCPDH CSNK1E PAH THNSL2 PLK4 HCLS1 | 2.39e-05 | 290 | 253 | 13 | CID000000866 |
| Drug | argiopine | 2.44e-05 | 16 | 253 | 4 | CID000122294 | |
| Drug | PQQ cofactor | 2.44e-05 | 16 | 253 | 4 | CID000363188 | |
| Drug | AC1L1AOE | 2.57e-05 | 32 | 253 | 5 | CID000001078 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 2.57e-05 | 32 | 253 | 5 | CID000001222 | |
| Drug | NADP | 2.63e-05 | 107 | 253 | 8 | ctd:D009249 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 3.00e-05 | 33 | 253 | 5 | CID000002071 | |
| Drug | emodin | CSNK1A1L CSNK1G1 UGT2B15 SEC61A1 VDAC1 CSNK1E SLC45A2 PRKD1 TOP2B | 3.10e-05 | 142 | 253 | 9 | CID000003220 |
| Drug | 7-Cl-Thio-Kyna | 3.16e-05 | 17 | 253 | 4 | CID003035668 | |
| Drug | DE gel | 3.28e-05 | 143 | 253 | 9 | CID000008146 | |
| Drug | D-CPPene | 3.48e-05 | 34 | 253 | 5 | CID006435801 | |
| Drug | arabinopyranose | GALM FCSK ADHFE1 GLB1 AGL GPC4 VDAC1 COL1A2 GPC6 SLC2A1 HAPLN1 TOP2B | 3.84e-05 | 261 | 253 | 12 | CID000000229 |
| Drug | DNQX | 3.90e-05 | 83 | 253 | 7 | CID003899541 | |
| Drug | kainite | 4.03e-05 | 35 | 253 | 5 | CID000164810 | |
| Drug | MNQX | 4.03e-05 | 18 | 253 | 4 | CID000130818 | |
| Drug | MesG | 4.43e-05 | 58 | 253 | 6 | CID003035490 | |
| Drug | AC1L1BXF | 4.55e-05 | 85 | 253 | 7 | CID000001650 | |
| Drug | thio-ATPA | 4.59e-05 | 7 | 253 | 3 | CID005289517 | |
| Drug | R,S)-AMPA | 4.63e-05 | 36 | 253 | 5 | CID000001221 | |
| Disease | Schizophrenia | CSMD2 ITGAM MAGI2 NRXN3 NUFIP2 SLC17A7 NLGN2 HSPA1L DPYD AMBRA1 GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B PPIA OPA1 TENM4 CSNK1E PAH CNTNAP2 DAAM2 | 3.57e-07 | 883 | 243 | 24 | C0036341 |
| Disease | Colorectal Carcinoma | WNK1 CSMD3 DSCAML1 TXNRD1 CDKL5 FAT1 CSNK1A1L NLGN4X HOXD1 FCN1 PKHD1 ABCG2 UHRF2 FLNC DPYD CAD HAPLN1 LIG3 PANK4 KDM2A PRKD1 | 4.32e-07 | 702 | 243 | 21 | C0009402 |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.42e-06 | 11 | 243 | 4 | DOID:9279 (implicated_via_orthology) | |
| Disease | Autistic Disorder | INPP1 CSMD3 NRXN3 NLGN4X DPYD GRIA1 GRIK2 NLGN1 GRIN2B CNTNAP2 CDH9 | 1.20e-05 | 261 | 243 | 11 | C0004352 |
| Disease | Bipolar Disorder | INPP1 ITGAM MAGI2 SLC17A7 GRIA1 GRIA2 GRIK1 GRIK2 GRIK4 NLGN1 GRIN2B TENM4 CSNK1E CNTNAP2 | 4.68e-05 | 477 | 243 | 14 | C0005586 |
| Disease | Autism Spectrum Disorders | 7.45e-05 | 85 | 243 | 6 | C1510586 | |
| Disease | Alcoholic Intoxication, Chronic | CYP2A13 DSCAML1 ADH4 NRXN3 NLGN4X GRIK1 GRIN2B CNTNAP2 CDH9 CDH11 | 8.32e-05 | 268 | 243 | 10 | C0001973 |
| Disease | Seizures | 8.77e-05 | 218 | 243 | 9 | C0036572 | |
| Disease | Epileptic encephalopathy | 1.04e-04 | 30 | 243 | 4 | C0543888 | |
| Disease | intellectual disability (is_implicated_in) | 1.04e-04 | 30 | 243 | 4 | DOID:1059 (is_implicated_in) | |
| Disease | X-19141 measurement | 1.48e-04 | 13 | 243 | 3 | EFO_0800799 | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 1.48e-04 | 13 | 243 | 3 | C0750905 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.48e-04 | 13 | 243 | 3 | C1846647 | |
| Disease | systolic blood pressure, cigarettes per day measurement | 1.48e-04 | 13 | 243 | 3 | EFO_0006335, EFO_0006525 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 1.48e-04 | 13 | 243 | 3 | C0002514 | |
| Disease | visceral adipose tissue measurement | SLC35C1 WNK1 KCNK9 MAGI2 NRXN3 PKHD1 DPYD GRIA1 NLGN1 GPC6 HAPLN1 TTC7A THNSL2 | 1.96e-04 | 481 | 243 | 13 | EFO_0004765 |
| Disease | hereditary sensory and autonomic neuropathy type 1 (implicated_via_orthology) | 2.02e-04 | 3 | 243 | 2 | DOID:0070162 (implicated_via_orthology) | |
| Disease | S-adenosylhomocysteine hydrolase deficiency | 2.02e-04 | 3 | 243 | 2 | C3151058 | |
| Disease | Hypermethioninemia | 2.02e-04 | 3 | 243 | 2 | C4048705 | |
| Disease | Hepatic methionine adenosyltransferase deficiency | 2.02e-04 | 3 | 243 | 2 | C0268621 | |
| Disease | cholic acid glucuronide measurement | 2.02e-04 | 3 | 243 | 2 | EFO_0800574 | |
| Disease | facioscapulohumeral muscular dystrophy (implicated_via_orthology) | 2.02e-04 | 3 | 243 | 2 | DOID:11727 (implicated_via_orthology) | |
| Disease | Hypermethioninemia due to deficiency of glycine N-methyltransferase | 2.02e-04 | 3 | 243 | 2 | C1847720 | |
| Disease | Tonic - clonic seizures | 2.27e-04 | 104 | 243 | 6 | C0494475 | |
| Disease | Myoclonic Seizures | 2.27e-04 | 104 | 243 | 6 | C4317123 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.77e-04 | 152 | 243 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Epilepsy | 2.93e-04 | 109 | 243 | 6 | C0014544 | |
| Disease | Craniofacial Abnormalities | 3.24e-04 | 156 | 243 | 7 | C0376634 | |
| Disease | serum metabolite measurement | TANC2 AOC1 GALNT2 ITGAM PTER ADH4 MAGI2 MGMT UGT2B15 ABCG2 D2HGDH KYNU DPYD KLHL1 GRIK2 GRIK4 SAR1B PAH DIRAS2 | 3.40e-04 | 945 | 243 | 19 | EFO_0005653 |
| Disease | Glycogen storage disease | 3.44e-04 | 17 | 243 | 3 | cv:C0017919 | |
| Disease | X-25937 measurement | 4.01e-04 | 4 | 243 | 2 | EFO_0800937 | |
| Disease | Glycogen phosphorylase kinase deficiency | 4.01e-04 | 4 | 243 | 2 | cv:C0268147 | |
| Disease | blood arsenic measurement | 4.85e-04 | 19 | 243 | 3 | EFO_0021527 | |
| Disease | Colorectal Neoplasms | 5.17e-04 | 277 | 243 | 9 | C0009404 | |
| Disease | amino acid measurement | TANC2 GALM GALNT2 ALX4 KLHL29 AP3S1 ABCG2 GRIK2 NLGN1 GRIN2B HAPLN1 TENM4 FAR2 GRIP2 HAS2 | 5.46e-04 | 678 | 243 | 15 | EFO_0005134 |
| Disease | Epilepsy, Cryptogenic | 5.92e-04 | 82 | 243 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 5.92e-04 | 82 | 243 | 5 | C0751111 | |
| Disease | Aura | 5.92e-04 | 82 | 243 | 5 | C0236018 | |
| Disease | cleft lip | 6.18e-04 | 284 | 243 | 9 | EFO_0003959 | |
| Disease | Huntington's disease (is_implicated_in) | 8.65e-04 | 23 | 243 | 3 | DOID:12858 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 9.57e-04 | 53 | 243 | 4 | C4707243 | |
| Disease | West Syndrome | 9.82e-04 | 24 | 243 | 3 | C0037769 | |
| Disease | Psychosexual Disorders | 9.91e-04 | 6 | 243 | 2 | C0033953 | |
| Disease | Hirschsprung's disease (is_marker_for) | 9.91e-04 | 6 | 243 | 2 | DOID:10487 (is_marker_for) | |
| Disease | Frigidity | 9.91e-04 | 6 | 243 | 2 | C0016722 | |
| Disease | Orgasmic Disorder | 9.91e-04 | 6 | 243 | 2 | C0029261 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 9.91e-04 | 6 | 243 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | primary open angle glaucoma (is_marker_for) | 9.91e-04 | 6 | 243 | 2 | DOID:1070 (is_marker_for) | |
| Disease | Hypoactive Sexual Desire Disorder | 9.91e-04 | 6 | 243 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 9.91e-04 | 6 | 243 | 2 | C0036902 | |
| Disease | ascending aortic diameter | 1.10e-03 | 140 | 243 | 6 | EFO_0021787 | |
| Disease | neuropsychological test | 1.29e-03 | 197 | 243 | 7 | EFO_0003926 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 1.38e-03 | 7 | 243 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | X-24574 measurement | 1.38e-03 | 7 | 243 | 2 | EFO_0800897 | |
| Disease | psoriasis (implicated_via_orthology) | 1.38e-03 | 7 | 243 | 2 | DOID:8893 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in medium LDL percentage | 1.39e-03 | 27 | 243 | 3 | EFO_0022238 | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.45e-03 | 100 | 243 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | interleukin 5 measurement | 1.55e-03 | 28 | 243 | 3 | EFO_0008185 | |
| Disease | Absence Seizures | 1.58e-03 | 102 | 243 | 5 | C4316903 | |
| Disease | Tonic Seizures | 1.58e-03 | 102 | 243 | 5 | C0270844 | |
| Disease | Seizures, Focal | 1.72e-03 | 104 | 243 | 5 | C0751495 | |
| Disease | lifestyle measurement, depressive symptom measurement | 1.80e-03 | 105 | 243 | 5 | EFO_0007006, EFO_0010724 | |
| Disease | childhood absence epilepsy (is_implicated_in) | 1.83e-03 | 8 | 243 | 2 | DOID:1825 (is_implicated_in) | |
| Disease | melanoma (implicated_via_orthology) | 1.83e-03 | 8 | 243 | 2 | DOID:1909 (implicated_via_orthology) | |
| Disease | deoxycholic acid glucuronide measurement | 1.83e-03 | 8 | 243 | 2 | EFO_0800575 | |
| Disease | phenol sulfate measurement | 1.83e-03 | 8 | 243 | 2 | EFO_0021011 | |
| Disease | alcohol use disorder measurement | 2.06e-03 | 214 | 243 | 7 | EFO_0009458 | |
| Disease | tuberculosis | 2.17e-03 | 216 | 243 | 7 | MONDO_0018076 | |
| Disease | Hyperkinesia | 2.29e-03 | 32 | 243 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 2.29e-03 | 32 | 243 | 3 | C0751217 | |
| Disease | Cleft palate, cleft lip | 2.30e-03 | 279 | 243 | 8 | EFO_0003959, HP_0000175 | |
| Disease | interleukin 25 measurement | 2.34e-03 | 9 | 243 | 2 | EFO_0008182 | |
| Disease | glycogen storage disease (is_implicated_in) | 2.34e-03 | 9 | 243 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | unipolar depression | GALM PIPOX CSMD3 MAGI2 LDHD FASN FAT1 PKHD1 SLC6A15 GRIK2 GRIK4 NLGN1 GRIN2B ECE1 OPA1 HAPLN1 LTO1 PPIL1 TNR CDH9 | 2.48e-03 | 1206 | 243 | 20 | EFO_0003761 |
| Disease | stroke outcome severity measurement | 2.58e-03 | 114 | 243 | 5 | EFO_0009603 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 2.68e-03 | 115 | 243 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | Prescription Drug Abuse | 2.68e-03 | 115 | 243 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 2.68e-03 | 115 | 243 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.68e-03 | 115 | 243 | 5 | C0029231 | |
| Disease | Drug habituation | 2.68e-03 | 115 | 243 | 5 | C0013170 | |
| Disease | Drug abuse | 2.68e-03 | 115 | 243 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 2.68e-03 | 115 | 243 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.68e-03 | 115 | 243 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.68e-03 | 115 | 243 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.68e-03 | 115 | 243 | 5 | C0038586 | |
| Disease | pack-years measurement, systolic blood pressure | 2.73e-03 | 34 | 243 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | Substance abuse problem | 2.78e-03 | 116 | 243 | 5 | C0740858 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.91e-03 | 10 | 243 | 2 | EFO_0022090 | |
| Disease | urea measurement | 2.91e-03 | 10 | 243 | 2 | EFO_0011005 | |
| Disease | high density lipoprotein particle size measurement | 2.93e-03 | 170 | 243 | 6 | EFO_0008592 | |
| Disease | depressive symptom measurement | 2.97e-03 | 426 | 243 | 10 | EFO_0007006 | |
| Disease | fatty acid measurement | ANKRD31 TTC39B GALNT2 DSCAML1 LIPG UGT2B15 UGT2B17 GRIA1 SLC6A15 GRIK2 | 3.50e-03 | 436 | 243 | 10 | EFO_0005110 |
| Disease | Semantic-Pragmatic Disorder | 3.54e-03 | 11 | 243 | 2 | C0454655 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 3.54e-03 | 11 | 243 | 2 | EFO_0801531 | |
| Disease | Auditory Processing Disorder, Central | 3.54e-03 | 11 | 243 | 2 | C0751257 | |
| Disease | Language Delay | 3.54e-03 | 11 | 243 | 2 | C0023012 | |
| Disease | Language Development Disorders | 3.54e-03 | 11 | 243 | 2 | C0023014 | |
| Disease | glycerophosphorylcholine measurement | 3.54e-03 | 11 | 243 | 2 | EFO_0020018 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 3.54e-03 | 11 | 243 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | visual epilepsy (is_implicated_in) | 3.54e-03 | 11 | 243 | 2 | DOID:11832 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKSARDVFTKGYGFG | 11 | P21796 | |
| DLGQLDGLGFLYVTG | 496 | Q5FVE4 | |
| GSVANVGGTLRYKGE | 256 | Q86TX2 | |
| GFGDAKSRARYGAGQ | 56 | Q9H161 | |
| AGYFGGVSGLSKAQF | 251 | O60909 | |
| AVAAYSNNGKLVGGA | 986 | Q96N23 | |
| GATFIYQGSVKGQGF | 3366 | Q7Z408 | |
| FIYTCGGTLKGLNGT | 61 | Q7Z407 | |
| IQGKDYGQFGLQRLG | 3596 | Q7Z407 | |
| NGNGKVDYGEFKRGI | 496 | Q9BXY5 | |
| GIQYEDKINVGGGLS | 381 | P07357 | |
| GEIVLYQKSLFSGNG | 1396 | Q68DQ2 | |
| NGGILSNYFKGTSGE | 151 | Q8N7X0 | |
| GFSTGYGAAINNAKV | 181 | P08319 | |
| YVLGDTLGVGTFGKV | 16 | P54646 | |
| VFIAGLGLYGSSSGK | 421 | Q96KE9 | |
| NLTQIGGLIDSKGYG | 766 | P39086 | |
| GLVIGAIYFGLKNDS | 406 | Q9UNQ0 | |
| LGKGASVLAVDENGY | 946 | O15084 | |
| GKALQYLGTFGELSN | 926 | Q12882 | |
| AGAISNGGLYVKLGQ | 136 | Q3MIX3 | |
| KGGFNFYAGLKGQVL | 436 | P19801 | |
| GLGLAYGTNKGDLVI | 1021 | Q9C0C7 | |
| EGGLLIGGSDNKLIY | 51 | Q92572 | |
| AKLGAVYTEGGFVEG | 21 | P19835 | |
| GGNVDGKFSVGYRDA | 1036 | Q9H251 | |
| GGLVNYRILSGAEGK | 1241 | Q9H251 | |
| AGKRIGVFSYGSGLA | 366 | Q01581 | |
| YQQLEGAGTVFGSKA | 126 | Q6P1R3 | |
| FGAGLASGANYKSVL | 151 | Q5U651 | |
| SGYSVANLAKDLGLG | 41 | Q9Y5E4 | |
| AYGLKILGTAGTEEG | 171 | Q08257 | |
| AAIGNQLYVFGGGER | 146 | Q7Z6M1 | |
| GLLGFGLGKVSYIGV | 91 | Q56VL3 | |
| RGGESIFGQLYGDQA | 61 | Q8WUA2 | |
| GGRVGKGIYFASENS | 406 | Q9Y6F1 | |
| GFGDYVALQTKGALQ | 201 | Q9NPC2 | |
| TGYINTAFLKGGEEG | 486 | O75106 | |
| VGGFYRTASELLKGG | 531 | Q8N7Z5 | |
| SGAFGKVVEGTAYGL | 601 | P16234 | |
| KGQRGGAYGFRVASL | 811 | Q86T65 | |
| TGFNGKLVYAVSGGN | 746 | Q14517 | |
| YSIRDGSGVGVFKIG | 1071 | Q14517 | |
| NAGGYAGNAVGFKLS | 306 | Q9C0D6 | |
| AFYGGKSILITGATG | 6 | Q96K12 | |
| GDRIFGAAGAGYKSL | 281 | P49441 | |
| ALGKVFTGGALYFGG | 246 | Q6N063 | |
| SGQFGIVYGGKHRKT | 591 | Q15139 | |
| RGVDLSGNDFKGGYF | 11 | Q13045 | |
| ELKGGAENGQFPYLG | 31 | Q86UL8 | |
| KITLIIGGSYGAGNY | 436 | Q9HCC0 | |
| GAGAFGKVVEATAYG | 596 | P10721 | |
| SGGGSFLLSGQVDYA | 141 | Q9GZZ0 | |
| VGGAVLGSLQFGYNT | 16 | P11166 | |
| GKGKSRYLFAVTGNG | 426 | O75487 | |
| DGYFGGARVQTGKLS | 591 | P46020 | |
| AHGGGAFSGKDYTKV | 276 | P31153 | |
| NKTFGSYLGVNLGFG | 61 | A6NL99 | |
| SSGAVGNYSGGLAVK | 151 | P16455 | |
| GCGNFGELRLGKNLY | 51 | Q9HCP0 | |
| FQYVGASADLKGGFD | 261 | Q10471 | |
| SDGKLFTFGNGDYGR | 4151 | Q15751 | |
| FGDGDYGKLGLGNST | 4211 | Q15751 | |
| GALQGLYTTVDFGTG | 231 | P16278 | |
| LFTVNQVEAGGSKYG | 86 | Q8NA75 | |
| LGENIADNGGLKAAY | 706 | P0DPD6 | |
| GFTDGDLLKIQFGGA | 241 | P42262 | |
| GGKAFLIAYGLFGCA | 141 | Q9HB15 | |
| SAGLSFGGGAGKYLA | 386 | Q8NCN5 | |
| EFGLGIYVSKVDHGG | 231 | Q9H5P4 | |
| GQAASDALGGYGSKE | 446 | Q6ZNL6 | |
| EFIVDTRNAGYGGLG | 2061 | Q14315 | |
| GLGFSIVGGKDSIYG | 226 | Q14005 | |
| NDPGATYIFGKSGGL | 1086 | Q9Y4C0 | |
| KNGGSILFYTGNEGD | 81 | P42785 | |
| GAHVAGYAGNFVKGT | 171 | Q9Y5X9 | |
| GYAGNFVKGTVGRIT | 176 | Q9Y5X9 | |
| AHGGGAFSGKDYTKV | 276 | Q00266 | |
| LLAVSNKYGLVFAGG | 41 | P35658 | |
| NKYGLVFAGGASGLQ | 46 | P35658 | |
| LGLGKEGITTYFSGN | 161 | Q9NY33 | |
| FLDLKSKGGNVGYGE | 346 | Q6YN16 | |
| AAIAYGLDKGGQGER | 181 | P34931 | |
| ASFDGRGSGYQGDKI | 576 | P27487 | |
| GKGLEYVSAISSNGG | 61 | A0A0J9YX35 | |
| RKIGSGSFGDVYLGI | 21 | Q8N752 | |
| GFIGVDGGKNISYAD | 86 | Q8NGQ2 | |
| GFLSTGDQAAKGNYG | 256 | Q8N2Q7 | |
| GDQAAKGNYGLLDLI | 261 | Q8N2Q7 | |
| EGSSGGIGERYKFLQ | 431 | Q9Y5B6 | |
| DLVVLGAFYGQGSKG | 691 | P49916 | |
| SYAAGSIIGKGGQTI | 41 | Q9UNW9 | |
| LGDKLYAVGGYDGQA | 706 | Q96PQ7 | |
| GFTQGDVGLAMGKLY | 206 | Q9UKI9 | |
| SGTLGKAFGCVGGYI | 386 | P22557 | |
| GQVGQAAYSASKGGI | 161 | Q99714 | |
| KAYGAGLLSSFGELQ | 341 | P00439 | |
| GGGGEAAAYNNKLVA | 366 | Q9P2V4 | |
| SDGKRFLGSGGFIGY | 146 | Q02809 | |
| SGFVTIRDLGGGEYQ | 46 | Q9UMZ3 | |
| YFKANGGGALVENTT | 86 | Q96BW5 | |
| EGYLGAIGAFLKGAE | 356 | Q9NVE7 | |
| LGYFAVVTGKGNSSE | 496 | O60313 | |
| KYKLVLGAFVGGSAG | 231 | O00602 | |
| GAGNIKTLGDAYEFA | 71 | Q9UBY9 | |
| LSTGDQAAKGNYGLL | 211 | Q8NFZ3 | |
| LAGAGGGGFLYLLTK | 1021 | Q8N0W3 | |
| NDYRVVVFGAGGVGK | 6 | O95057 | |
| SGYGKYLGINSDGLV | 111 | Q14331 | |
| TLGGLFGFAIGYVTG | 271 | Q96A29 | |
| YTGNFLDGTLKGKNG | 281 | Q96C23 | |
| KTSGGQGYKFLGIDQ | 166 | O60353 | |
| IAKSDGIAGLYQGFG | 176 | Q9H0C2 | |
| NFAAQYDGKGVGLGP | 76 | P08123 | |
| GEVRQAYGAKGFSLA | 31 | Q9Y625 | |
| GIGGTFQFGYNLSII | 21 | Q9BYW1 | |
| VKGKLYSIGGHGNFS | 451 | Q9NVR0 | |
| LGGFLYAVGGQDGVS | 411 | Q9Y2M5 | |
| VANGVNLDYDGLGKT | 396 | Q9Y2K7 | |
| FKGYGVAFSNGERAK | 111 | Q16696 | |
| GDNGGSSIRGFVLQY | 1406 | Q8TD84 | |
| VLASVGDTDFGYGKG | 66 | Q96C92 | |
| DGSIKYILSGEGAGI | 91 | Q9HBT6 | |
| FKGYGVAFSNGERAK | 111 | P20853 | |
| NDYRVAVFGAGGVGK | 6 | Q96HU8 | |
| LIFGGRVLNGYGLSK | 791 | Q8ND61 | |
| AAGYNLTGLFVGSEG | 236 | Q86WU2 | |
| GGVGGDVQILNKYDS | 236 | Q92819 | |
| GNIKYILSGEGAGTI | 86 | P55287 | |
| YGGLDVLVNNAGIAF | 81 | P16152 | |
| HYSIQKGAAFLGLGT | 191 | Q9Y600 | |
| DRGGKGLLLGGYNEF | 71 | Q5I0G3 | |
| AITGYDGNLGDLGKL | 816 | O15068 | |
| IVLGGFSQGGALSLY | 116 | O95372 | |
| GAKIGSEIGCYQGFA | 46 | Q8WV07 | |
| AKLYGADGLVFGALT | 106 | Q9NTM9 | |
| GYTLDSNKGGGHQTL | 786 | Q08554 | |
| ANGLFGEKSYDFLTG | 61 | A8MTL9 | |
| GGKNQELGAVSLDGY | 271 | Q5VU92 | |
| GSLKYILSGDGAGDL | 86 | P55285 | |
| LELYSQLFVGGAGGQ | 916 | Q9UHC6 | |
| GKDIAFIVHGYGGLV | 226 | A6NC97 | |
| GDGKVFIYHGSSLGV | 451 | Q13683 | |
| GRGGAKETYGIVAQA | 496 | Q32P44 | |
| AARQKVLVTGGGGYL | 31 | A6NKP2 | |
| GENIADNGGLKAAYR | 666 | P42892 | |
| ASYLGDNLRGIGSKF | 2726 | Q5TBA9 | |
| KVGGNLDSKGYGIAT | 736 | P42261 | |
| AGRDGAAGGKINKNY | 41 | Q8IXS0 | |
| NLTQIGGLIDSKGYG | 751 | Q13002 | |
| NLTQIGGLLDTKGYG | 736 | Q16099 | |
| LYKEGNSFGFVLRGG | 151 | Q9C0E4 | |
| SYIIAGGLGGFGLEL | 1886 | P49327 | |
| NGSYEALKGGSAIEA | 181 | O14815 | |
| NKFEILGVVGEGAYG | 11 | O76039 | |
| KGGSYVALTDGLGNL | 366 | P54803 | |
| AVITGAGDGIGKAYS | 51 | P37058 | |
| AGDGIGKAYSFELAK | 56 | P37058 | |
| DFTHKKQSGGAGQYG | 536 | Q96RP9 | |
| AAKAAKYGAAGAGVL | 446 | P15502 | |
| YGDVGKGCAQALRGF | 221 | P23526 | |
| VAGIFGAKYVVGAGL | 131 | Q9Y2C5 | |
| FTGFGGALGYLLGAI | 186 | Q9UMX9 | |
| GNLKYILTGDGAGSL | 86 | Q9ULB4 | |
| FLSTGDQAAKGNYGL | 221 | Q8NFZ4 | |
| LSTGDQAAKGNYGLL | 211 | Q8N0W4 | |
| NTGYDLKQLFIGSEG | 246 | Q8N465 | |
| DGYFGGARVKLGNLS | 591 | P46019 | |
| GGYQGRVFLKGGSDS | 106 | P10915 | |
| NAGAVDGKLYVCGGF | 546 | Q3ZCT8 | |
| IHGKNGLLFTYGVTG | 101 | Q02241 | |
| AQKGAFDAYVAVGGG | 126 | Q8IWW8 | |
| GEGAYAKVQGAVSLQ | 56 | Q9BUB5 | |
| DLKNQLGDAGYVLFG | 281 | O60478 | |
| EFTEGNFAILALGGG | 81 | Q9NX20 | |
| NDAIGKVFVGYNSTG | 371 | P21579 | |
| FLGGLRIGFGTGKSY | 876 | Q9HCH5 | |
| EGEKGAVVAGSRGYF | 181 | P49591 | |
| ESFLLQTGYAAGKGV | 186 | O15211 | |
| GLGFGGVIAFSSYNK | 311 | Q9H2J7 | |
| GESYFGVSSLQLKGQ | 1046 | Q9UQ35 | |
| DELLQKGYGLGSGIS | 166 | Q9H9S3 | |
| KGYGLGSGISLFIAT | 171 | Q9H9S3 | |
| GGRNGYGAKLCNIFS | 181 | Q02880 | |
| VALATGEKGYGYKGS | 71 | P45877 | |
| FRALSTGEKGFGYKG | 36 | P62937 | |
| VYGGVLRGTGKQAFG | 426 | Q86VL8 | |
| TSLFGAAGAGLTGYK | 241 | Q5TGY1 | |
| AADKGVYIIGSSGFD | 141 | Q8NBX0 | |
| KGQTALGFLYASGLG | 256 | Q9UBV2 | |
| AKGFGGQYGIQKDRV | 191 | P14317 | |
| LKELIGAGGFGQVYR | 126 | Q5TCX8 | |
| GGYLKGLLTAAESAF | 266 | Q969Y0 | |
| NGKFLDNGGSGYILK | 446 | Q86YW0 | |
| GGNKLGAGTLAAGYQ | 291 | Q6ZMB5 | |
| GAGYLALLQVATFKG | 1406 | Q14524 | |
| GFLLLISTVAGGKYG | 11 | Q8IUH8 | |
| RVGFYDIEGTLGKGN | 16 | Q9H0K1 | |
| TGGGYLFIGVDDKSR | 241 | Q7Z7L1 | |
| AFVVGGGIYFLGQAD | 166 | Q9Y2E8 | |
| FGLYGQTTGKGNVTL | 151 | Q9NR31 | |
| GAAGNLAAGYIAQKI | 261 | Q86YJ6 | |
| KYAGESSKELGSGGN | 196 | Q9HCD6 | |
| GLGLFGGRGEYTAKI | 1266 | O75592 | |
| DYGLGNSKGDRGNIS | 2706 | O75592 | |
| QHFGFKYVIGIGVGA | 101 | Q9ULP0 | |
| IGVGAGAYVLAKFAL | 111 | Q9ULP0 | |
| GGVIFYGVFASGEKQ | 481 | Q9P2U7 | |
| GALLVTQSKGVIGYG | 3711 | P08F94 | |
| KSFGASGGYIAGRKD | 371 | Q9NUV7 | |
| ANVKGTQIGAYFGAS | 446 | P11215 | |
| NLLGKGSFAGVYRAE | 16 | O00444 | |
| VYIDGKLSDGGAGLS | 1526 | Q4LDE5 | |
| GSQAAAAGLKEGDYI | 541 | Q8TCX5 | |
| IGKGSFGEVYKGIDN | 26 | O00506 | |
| AALQIFYSLGVGFGG | 291 | Q99884 | |
| HYILGDTLGVGTFGK | 26 | Q13131 | |
| YSVTGGGDQGIFVKQ | 126 | Q8IVF2 | |
| GTGGVGDKRQLVYVF | 156 | Q9Y4C5 | |
| RGAAGCTFGGKVYAL | 46 | Q9H2X0 | |
| GSGGLAAAKEAAQYG | 171 | Q16881 | |
| RGDEFTYTGSGGKNL | 501 | Q96PU4 | |
| FQSLYGDGSGGSVVL | 51 | P10074 | |
| SQELGYGCLKFGGQA | 96 | Q9BX73 | |
| GEQLKAEGGYFGQIR | 706 | Q8NI27 | |
| EFEGGVKLGSGAFNL | 296 | Q5VTQ0 | |
| KTGYGELNGNAGERE | 91 | Q7Z417 | |
| YGGSQGNLIFGKGTK | 1 | A0A075B6Y9 | |
| GRGGASIYGKQFEDE | 71 | Q9Y3C6 | |
| DELLQKGYGLGSGIS | 166 | P61619 | |
| KGYGLGSGISLFIAT | 171 | P61619 | |
| FGASGGYIGGKKELI | 381 | O15270 | |
| SGFGGKYGVQADRVD | 156 | Q14247 | |
| REGVLYAGSGTKNGS | 946 | P38935 | |
| LSNGYQLGKTIGEGT | 6 | Q96PN8 | |
| FGGVIGYSGDDINKF | 661 | Q8TCJ2 | |
| LKYGLVGGEGGRTTF | 536 | Q92752 | |
| LIFGKYFSHGGGQDV | 11 | Q9HBX9 | |
| FNVSLGKAALVGIYG | 466 | Q6N022 | |
| KTSGEYKLAGVFLGG | 86 | Q5JUR7 | |
| GSVIYDGKGFTSGRQ | 1446 | Q86WI1 | |
| FEKAYQVGAVLGSGG | 36 | Q86V86 | |
| SGGLSIGQAGEFDYS | 401 | P27708 | |
| GTVAGSAAGLKLYLN | 1546 | P27708 | |
| AAYGGLNEKSFVDGL | 311 | P50616 | |
| QVKLFLSQGGYHGSG | 371 | Q9HCJ5 | |
| GYLLGINLGEGSYAK | 11 | Q9BXA7 | |
| GIALYYGEIGNFKEG | 281 | Q7Z7G8 | |
| FSQLGGLEKDGSFGE | 636 | Q9ULT0 | |
| FGAGTYVGLTCKGID | 436 | O95361 | |
| AAVGAGLQKIGNTFY | 76 | P0C7H9 | |
| KYDNIVIGAGFSGHG | 336 | Q9P0Z9 | |
| SVGYTFEKNGGGFLF | 176 | P54855 | |
| DDSGSLLGFKYGSGQ | 441 | Q96RS0 | |
| GKDDYGFSGSQKLEG | 1211 | Q9H4A3 | |
| FGLYGQTTGKGSISL | 151 | Q9Y6B6 | |
| ALAVLKGFRNGAVYG | 26 | Q9Y6I8 | |
| GYIVGINLGKGSYAK | 11 | Q96PF2 | |
| LAALGGISGYAKVGS | 21 | Q6UXP3 | |
| SVGYTVEKNGGGFLF | 176 | O75795 | |
| LKLVDISYGGENGFN | 251 | P62495 | |
| QFVKGFGGIGGILRY | 401 | P62495 | |
| LQGNEKSGGGYIVVD | 96 | P35573 | |
| RYEGEFAQGKFNGVG | 61 | Q8NDC4 | |
| GSGSFGDIYLGANIA | 16 | P49674 | |
| YDGKIYTLGGLGVAG | 681 | Q96CT2 | |
| KIYVFGGVNEAGRAA | 731 | Q96CT2 | |
| AALNGKLYSVGGRDG | 596 | Q9NR64 | |
| AVLNGLLYAVGGFDG | 396 | O95198 | |
| KYLNAGAGGIAGAFI | 276 | Q16719 | |
| KGQGAILALAGDLAY | 221 | Q9H400 | |
| IGSGKVFASTGYGIA | 751 | Q13224 |